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ABSTRACT 
The present disclosure relates , according to some embodi 
ments , to methods , devices , and systems for fluid delivery to 
a subject using pumps , for example , non - gassing , direct 
current ( DC ) , electro - osmotic pumps . In some embodi 
ments , delivery of an aqueous fluid may be achieved by 
contacting the aqueous liquid with an electro - osmotic pump 
comprising ( i ) a cathode ( e . g . , a cathode comprising porous 
carbon coated with a cerium oxide - comprising coating ) , ( 11 ) 
an anode ( e . g . , an anode comprising porous carbon coated 
with a cerium oxide - comprising coating ) , and ( iii ) a ceramic 
membrane ( e . g . , a ceramic membrane formed by fusing 
uncoated silica spheres , phosphosilicic - acid - coated fused 
silica spheres , or borosilicic - acid - coated fused silica 
spheres , wherein the fused spheres are randomly packed 
between the cathode and the anode ) and / or optionally apply 
ing ( a ) a constant potential difference or constant voltage 
between the anode and the cathode of from about 0 . 1 V to 
about 3 V between the anode and the cathode of from about 
0 . 1 V to about 3 V such that the aqueous liquid is pumped 
or ( b ) constant current to cause a potential difference 
( Continued ) 
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between the anode and the cathode of from about 0 . 1 V to 
about 3 V such that the aqueous liquid is pumped . 
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ELECTRO - OSMOTIC PUMPS WITH distance from each other and a porous membrane compris 
ELECTRODES COMPRISING A ing a first side and a second side . In some embodiments , a 
LANTHANIDE OXIDE OR AN ACTINIDE DC component of the applied current or applied voltage 
OXIDE causes most of the flow of the pumped fluid in a direct 
5 current ( DC ) electro - osmotic pump . This does not mean or 
CROSS - REFERENCE TO RELATED imply that the applied voltage or current has no AC com 
APPLICATIONS ponent . According to some embodiments , a membrane may 
be positioned between the pair of electrodes . In some 
This application is claims priority to U . S . Provisional embodiments , at least a part of the first side of the membrane 
Application No . 61 / 704 . 268 , filed Sep . 21 , 2012 , the con - 10 is in physical contact with one of the electrodes and at least 
tents of which are hereby incorporated in their entirety by a part of the second side of the membrane is in physical 
reference . contact with the other electrode . 
In some embodiments , one or more electrodes of a 
FIELD OF THE DISCLOSURE non - gassing electro - osmotic pump may include a non - me 
15 tallic electrical conductor . For example , an electrode may 
The present disclosure relates , in some embodiments , to comprise carbon ( e . g . , carbon paper ) . An electrode may be 
methods , devices , and systems for drug delivery using substantially free of metal ( e . g . , substantially free of metallic 
pumps , for example , non - gassing , direct current ( DC ) , elec conductors ) , according to some embodiments . A substan 
tro - osmotic pumps . tially metal - free electrode may be operable as an electrode 
20 on the basis of one or more non - metallic components , for 
BACKGROUND OF THE DISCLOSURE example , non - metallic electrical conductors . 
Easy to make , potentially inexpensive , low voltage , non 
Electro - osmotic pumps are mechanically less complex water electrolyzing electro - osmotic pumps are disclosed . 
than other pumps ; typically they have fewer components . Such pumps may be used , for example , in drug infusion 
particularly fewer moving components . Small pumps are 25 systems , such as ambulatory drug infusion systems , that are 
widely used both in ambulatory and in non - ambulatory drug optionally small and skin - adhered . In some embodiments , 
delivery systems , including systems comprising a skin pumps are simple : they may comprise a porous ceramic 
adhered drug reservoir and pump . For example , skin - ad " membrane ” sandwiched between two porous electrodes . 
hered insulin " pumps ” are in use . Their pumps are often An exemplary membrane is a porous silica comprising 
mechanical . Electro - osmotic pumps for drug delivery have 30 membrane , optionally also comprising phosphosilicic acid 
been considered for 40 years or more , but none were sold functions . Water flows when a potential or a current is 
Electro - osmotic pumps that are manufactured and sold are applied . Pumps including electrodes comprising Ag and 
applied in compact bioanalytical systems and in heat pumps . Ag , 0 were described in patent application WO 2011 / 
In some of these , the pumps now drive liquids through long 112723 and in W . Shin et al J . Am . Chem . Soc . 133 , 
and narrow on - chip and off - chip capillaries and through 35 2374 - 2377 ( 2011 ) ; Drug Deliv . and Transl . Res . 1 : 342 - 347 
miniature packed chromatographic columns . Pumps have ( 2011 ) ; Analytical Chemistry 83 ( 12 ) , 5023 - 5025 ( 2011 ) and 
been integrated in silicon chips and are part of lab - on - chip by R . K . Nagarale et al . Journal of the Electrochemical 
devices . While polymeric ion exchange membranes were Society 159 ( 1 ) , P 14 - P 17 ( 2012 ) , each of which is incor 
used in the early pumps , the more recent pumps have porated herein in its entirety by reference . Electrodes com 
ceramic membranes , particularly of porous silica , although 40 prising Ag and Ag , O may be exhausted during pump 
porous silicon and aluminum oxide have also been used . operation because , as current passes between the electrodes , 
Platinum electrodes , on which water is electrolyzed at the the Ag may be electrooxidized and / or the Ag20 may be 
applied high voltages ranging from 3V to 400V , are usually electroreduced . Also , dissolving Ag + ions may contaminate 
used . Gas bubbles resulting from electrolysis , however , may the membranes of the pumps , reducing the pumping rate 
interfere with the operation of the pumps . Electro - osmotic 45 ( flow ) and the pumping efficiency , which may in turn 
pumps having ceramic membranes and gas - evolving elec - shorten the useful life of the battery powering the pump . 
trodes have been sold , for example , by NI ( Nano Fusion Accordingly , a need exists for inexpensive , reliable 
Technologies , Tokyo ) . Fouling may occur during pump pumps for delivery of fluids to a subject . For example , a 
operation due , for example , to migration of ions from the need has arisen for pumps capable of delivering a fluid ( e . g . , 
electrodes to the pump ' s membrane . 50 a fluid comprising a drug , allergen , and / or other physiologi 
cally relevant compound ) to a subject at desired intervals 
SUMMARY and / or rates ( substantially ) without fouling . A need has 
arisen for improved pumps ( e . g . , electro - osmotic pumps ) 
The present disclosure relates , according to some embodi providing a constant flow when a constant current or poten 
ments , to devices , systems , and methods for delivering a 55 tial is applied . In some electro - osmotic pumps , membrane 
composition to a subject ( e . g . , human and / or animal ) . fouling due to metal ion migration ( e . g . , silver ion migra 
According to some embodiments , an electro - osmotic pump tion ) from an electrode may reduce the flow . 
system suitable for use , for example , in drug delivery An electro - osmotic pump may include electrodes com 
systems , providing stable flow is disclosed . An optionally prising silver and / or silver oxide . According to some 
on - the - skin drug - delivering system may be of low - cost , 60 embodiments of the present disclosure , an electro - osmotic 
replaceable and small . In some embodiments , the present pump may include electrodes comprising a lanthanide oxide 
disclosure relates to an electro - osmotic pump having lan - and / or an actinide oxide in place of silver / silver oxide 
thanide oxide or actinide oxide comprising electrodes , for electrodes . For example , an electrode may comprise a 
example , electrodes comprising cerium oxide nanoparticles . nanocrystalline oxide of cerium , thorium and / or praseo 
For example , a direct current ( DC ) electro - osmotic pump 65 dymium . In some embodiments , cerium oxide may be 
may comprise a pair of porous electrodes ( e . g . , comprising preferred . The metal oxide may be a mixed oxide , containing 
an oxide of a lanthanide or of an actinide ) positioned at a two or more lanthanides or actinides , or one or more 
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lanthanides and one or more transition metals . Other than a drug cartridge . A delivery system may be worn by a subject 
metal oxide ( e . g . , cerium oxide ) , an electrode may comprise ( e . g . , adhered to a subject ' s skin ) in some embodiments . An 
a conductor , such as carbon , and an ion - conducting , prefer - electro - osmotic fluid delivery system may comprise , in 
ably proton conducting , polymeric material , such as a sul some embodiments , a needle or cannula in fluid communi 
fonated tetrafluoroethylene based fluoropolymer - copolymer 5 cation with a delivery fluid chamber and configured for 
( NAFION® ) . The average size of the lanthanide oxide or an insertion into a subject . A kit may comprise an electro 
actinide oxide nanocrystallites may be less than about 50 osmotic fluid delivery system and instructions for adminis 
nm ; it can be , for example , 30 nm or less , 20 nm or less , or t ering a drug to a subject using the system . A direct current 
10 nm or less . In some embodiments , electrodes may be electro - osmotic pump may comprise , in some embodiments , 
substantially free of all metal . 10 a porous cathode and a porous anode , each comprising 
A lanthanide oxide or actinide oxide may be insulating or cerium oxide , and a porous ceramic membrane between the 
conducting , according to some embodiments . Electrodes cathode and the anode , wherein at least a part of the surface 
may also comprise , in some embodiments , a conductor such of the membrane is in physical contact with the anode and 
as carbon . The durability of the pumps may increase ( e . g . , at least a part of the opposite side of the membrane is in 
greatly increased ) relative to pumps made with silver and / or 15 physical contact with the cathode . 
silver oxide electrodes . While pumps made with Ag / Ag2O According to some embodiments , the disclosure relates to 
electrodes may operate at non - water electrolyzing condi a method to produce an electro - osmotic pump comprising 
tions for about 2 + 1 hours , pumps of this disclosure with the steps of ( a ) adding an aqueous solution of phosphoric 
silver - free electrodes , may operate for longer than ~ 3 hours , acid and / or an aqueous solution of boric acid to a suspension 
longer than ~ 4 hours , longer than ~ 5 hours , longer than ~ 7 20 of silica microspheres having a diameter between about 0 . 5 
hours , longer than ~ 10 hours , longer than ~ 20 hours , or um and about 3 um to form a suspension , ( b ) evaporating the 
longer than ~ 100 hours . water from the suspension to form a powder , ( C ) pressing the 
In pumps made with Ag / Ag20 electrodes , Ag + ions may powder to form a pellet having at least two opposite sur 
migrate , and their migration and binding to the membrane faces , ( d ) firing the pellet for about 1 to about 6 hours at a 
may reduce flow across the membrane . In the absence of 25 temperature from about 700° C . to about 900° C . to form the 
flow - affecting Ag + ions , the flow through the pumps with ceramic membrane , ( e ) washing the ceramic membrane , ( f ) 
silver - free electrodes may be more stable , reproducible , drying the ceramic membrane , and / or ( g ) pressing two 
and / or controllable . porous carbon electrodes coated with cerium oxide - com 
The present disclosure relates , in some embodiments , to prising coatings onto opposite surfaces of the ceramic mem 
direct current electro - osmotic pumps comprising a pair of 30 brane to form an electrode - membrane - electrode sandwich . 
porous electrodes positioned at a distance from each other I n some embodiments , delivery of an aqueous fluid may 
and a porous membrane ( e . g . , interposed between the elec - be achieved by contacting the aqueous liquid with an 
trodes ) comprising a first side and a second side . In some electro - osmotic pump comprising ( i ) a cathode ( e . g . , a 
embodiments , a membrane may comprise porous ceramic , cathode comprising porous carbon coated with a cerium 
for example , a porous ceramic comprising silicon ( e . g . , 35 oxide - comprising coating ) , ( ii ) an anode ( e . g . , an anode 
vitreous silicon dioxide ) . At least one electrode may com comprising porous carbon coated with a cerium oxide 
prise , according to some embodiments , an oxide of a lan - comprising coating ) , and ( iii ) a ceramic membrane ( e . g . , a 
thanide or of an actinide . For example , at least one electrode ceramic membrane formed by fusing uncoated silica 
may comprise an oxide of cerium , an oxide of praseo - spheres , phosphosilicic - acid - coated fused silica spheres , or 
dymium , an oxide of thorium or combinations thereof . In 40 borosilicic - acid - coated fused silica spheres , wherein the 
some embodiments , both electrodes may be substantially fused spheres are randomly packed between the cathode and 
free from all metal . The composition of each electrode in a the anode ) , and / or optionally applying ( a ) a constant poten 
pump may be the same or different from the other tial difference or constant voltage between the anode and the 
electrode ( s ) in the pump . For example , both electrodes in a cathode of from about 0 . 1 V to about 3 V between the anode 
two - electrode pump may comprise an oxide of cerium . At 45 and the cathode such that the aqueous liquid is pumped or 
least a part of the first side of the membrane may be in ( b ) constant current to cause a potential difference between 
physical contact with one of the electrodes and at least a part the anode and the cathode of from about 0 . 1 V to about 3 V 
of the second side of the membrane is in physical contact such that the aqueous liquid is pumped . 
with the other electrode in some embodiments . At least one In some embodiments , an electro - osmotic pump may 
electrode may be substantially free ( e . g . , free ) of a metal 50 comprise a layered composition . According to some 
selected from silver , platinum , palladium , nickel , copper , embodiments a layered composition may comprise : ( i ) a first 
tungsten , molybdenum , and combinations thereof . Accord - layer comprising a porous substrate and a coating contacting 
ing to some embodiments , at least one electrode may com - at least a portion of the substrate ; ( ii ) a second layer 
prise carbon and / or a cation exchanging polymer ( e . g . , a comprising a porous silica matrix ; ( ii ) a third layer com 
cation exchanging polymer comprising sulfur atoms , a cat - 55 prising a porous substrate and a coating contacting at least 
ion exchanging polymer comprising fluorine atoms , a cation a portion of the substrate . In some embodiments , the coating 
exchanging polymer comprising perfluorinated polysulfonic may comprise a ceria , cerium oxide or a combination of 
acid ) . A direct current electro - osmotic pump may comprise , ceria and cerium oxide . In some embodiments , at least a 
in some embodiments , a pump fluid ( e . g . , water ) . portion of the first layer may be in contact with the second 
The present disclosure relates to an electro - osmotic fluid 60 layer and at least a portion of the third layer may be in 
delivery system comprising a direct current electro - osmotic contact with the second layer . In some embodiments , a 
pump and a reservoir . A reservoir may comprise , for p orous substrate of a composition layer may comprise 
example , a pump fluid chamber in fluid communication with carbon ( e . g . , non - woven carbon paper or cloth ) . In some 
the electro - osmotic pump and a delivery fluid chamber in embodiments , a layered composition may be substantially 
fluid communication with the electro - osmotic pump , accord - 65 free ( e . g . , free ) of silver , substantially free ( e . g . , free ) of 
ing to some embodiments . According to some embodiments , platinum , or substantially free ( e . g . , free ) of silver and 
a delivery fluid chamber may be configured as a disposable platinum . A layered composition may comprise ( e . g . , have a 
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coating comprising ) a polyanionic membrane ( e . g . , perfluo FIG . 3A illustrates an exploded view of the pump shown 
rosulfonic acid / polytetrafluoroethylene copolymer or a per - in FIG . 3B according to a specific example embodiment of 
fluorosulfonic acid / polytetrafluoroethylene copolymer ) . the disclosure ; 
An electro - osmotic fluid delivery system may comprise , FIG . 3B illustrates an assembled pump according to a 
in some embodiments , ( a ) an electro - osmotic pump com - 5 specific example embodiment of the disclosure ; 
prising ( i ) a porous cathode comprising Cet + ions , ( ii ) a FIG . 4A illustrates a plan view of a reservoir system 
porous anode comprising Ce * + ions and ( iii ) a porous according to a specific example embodiment of the disclo 
ceramic membrane between the cathode and the anode , sure ; 
wherein at least a part of the surface of the membrane is in FIG . 4B illustrates a plan view of a 0 . 9 mL volume 
physical contact with the anode , and at least a part of the 10 reservoir system according to a specific example embodi 
opposite side of the membrane is in physical contact with the ment of the disclosure ; 
cathode ; ( b ) a reservoir comprising a pump fluid chamber in FIG . 4C illustrates a plan view of a 2 . 7 mL reservoir 
fluid communication with the electro - osmotic pump and a system according to a specific example embodiment of the 
delivery fluid chamber in fluid communication with the disclosure ; 
electro - osmotic pump ; ( c ) a removable controller assembly 15 FIG . 4D illustrates a plan view of a 7 . 3 mL reservoir 
in electrical communication with the anode and the cathode ; system according to a specific example embodiment of the 
and / or ( d ) a needle in fluid communication with the delivery disclosure ; 
fluid chamber . A needle may be configured , in some embodi - FIG . 5A illustrates an exploded view of a pump according 
ments , to be in fluid communication with a delivery fluid to a specific example embodiment of the disclosure ; 
chamber at one end and in fluid communication with a 20 FIG . 5B illustrates a plan view of a reservoir system 
subject at the other . In some embodiments , electrodes may according to a specific example embodiment of the disclo 
be configured to be renewed , for example , by making the sure ; 
cathode the anode and making the anode the cathode . FIG . 5C is a sectional view of a reservoir system accord 
The present disclosure relates , according to some embodi - ing to a specific example embodiment of the disclosure 
ments , to a prefilled electro - osmotic pump fluid reservoir 25 along section lines 5C - 5C shown in FIG . 5B ; 
comprising ( a ) a removable plug having a first plug surface , FIG . 5D is a sectional view of a reservoir system accord 
a second plug surface , and a pull - tab coupled to the first plug ing to a specific example embodiment of the disclosure 
surface and the second plug surface ; ( b ) a first , generally along section lines 5D - 5D shown in FIG . 5B ; 
tubular fluid chamber having a first opening and at least one FIG . 5E is a sectional view of a reservoir system accord 
curvature having a concave edge , wherein the first plug 30 ing to a specific example embodiment of the disclosure 
surface is positioned to form a fluid - tight seal with the first along section lines 5E - 5E shown in FIG . 5B ; 
opening of the first chamber ; and / or ( c ) a second , generally FIG . 5F illustrates an elevation view of the reservoir 
tubular fluid chamber having a first opening and at least one system shown in FIG . 5B according to a specific example 
curvature having a concave edge , wherein the second plug embodiment of the disclosure ; 
surface is positioned to form a fluid - tight seal with the first 35 FIG . 5G is a sectional view of a reservoir system accord 
opening of the second chamber . A first fluid chamber may ing to a specific example embodiment of the disclosure 
contain ( e . g . , be at least partially filled with ) a first fluid along section lines 56 - 5G shown in FIG . 5F ; 
( e . g . , a pump fluid ) and / or a second fluid chamber may FIG . 5H is a sectional view of a reservoir system accord 
contains ( e . g . , be at least partially filled with ) a second fluid ing to a specific example embodiment of the disclosure 
( e . g . , a delivery fluid ) . In some embodiments , a delivery 40 along section lines 5H - 5H shown in FIG . 5F ; 
fluid may comprise at least one active pharmaceutical ingre - FIG . 51 illustrates a generally isometric view of the 
dient ( e . g . , a drug ) . In some embodiments , a prefilled reservoir system shown in FIGS . 5B - 5H ; 
electro - osmotic pump fluid reservoir may comprise ( a ) a FIG . 5J illustrates a generally isometric view of the 
first , generally tubular fluid chamber having a first opening reservoir system shown in FIGS . 53 - 51 ; 
and at least one curvature having a concave edge , wherein 45 FIG . 6A illustrates an elevation view of a pump system 
the first opening of the first chamber is ( i ) fluidly sealed by according to a specific example embodiment of the disclo 
a first elastomeric septum and ( ii ) configured to removably sure ; 
engage at least a portion of an electro - osmotic pump ; and / or FIG . 6B illustrates a plan view of a pump system accord 
( b ) a second , generally tubular fluid chamber having a first ing to a specific example embodiment of the disclosure ; 
opening and at least one curvature having a concave edge , 50 FIG . 6C illustrates an isometric view of a pump system 
wherein the first opening of the second chamber is ( i ) fluidly according to a specific example embodiment of the disclo 
sealed by a second elastomeric septum ( ii ) configured to sure ; 
removably engage at least a portion of the electro - osmotic FIG . 6D illustrates a plan view of a constant current / 
pump , wherein the first fluid chamber contains a first fluid voltage controller and timer according to a specific example 
and the second fluid chamber contains a second fluid . 55 embodiment of the disclosure ; 
FIG . 6E illustrates a plan view of a constant current / 
BRIEF DESCRIPTION OF THE DRAWINGS voltage controller and timer according to a specific example 
embodiment of the disclosure ; 
Some embodiments of the disclosure may be understood FIG . 6F illustrates a plan view of a constant current / 
by referring , in part , to the present disclosure and the 60 voltage controller and timer according to a specific example 
accompanying drawings , wherein : embodiment of the disclosure ; 
FIG . 1 illustrates a sectional view of the structure of a FIG . 7A illustrates a sectional view of a pump system 
pump according to a specific example embodiment of the according to a specific example embodiment of the disclo 
disclosure ; sure ; 
FIG . 2 illustrates a sectional view of a pump with elec - 65 FIG . 7B illustrates a sectional view of a pump system 
trode reactions and transport processes according to a spe - according to a specific example embodiment of the disclo 
cific example embodiment of the disclosure ; sure ; 
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FIG . 7C illustrates a sectional view of a pump system FIG . 13C illustrates a generally isometric view of the 
according to a specific example embodiment of the disclo pump system shown in FIGS . 13A - 13B in which fluid 
sure ; continues to move through drug outlet according to a 
FIG . 8A illustrates a sectional view of a pump system specific example embodiment of the disclosure ; 
according to a specific example embodiment of the disclo - 5 FIG . 13D illustrates a generally isometric view of the 
sure in which the water chamber is being filled with water ; pump system shown in FIGS . 13A - 13C in which fluid 
FIG . 8B illustrates a sectional view of the pump system movement through drug outlet has been stopped according 
shown in FIG . 8A in which the water - filled water chamber to a specific example embodiment of the disclosure ; 
is being capped with oil according to a specific example FIG . 14 is a scanning electron micrograph that illustrates 
embodiment of the disclosure ; 10 a pump membrane according to a specific example embodi 
FIG . 8C illustrates a sectional view of the pump system ment of the disclosure ; FIG . 15 illustrates the voltage dependence of the flow shown in FIG . 8B in which the drug chamber is being filled 
with a water primer according to a specific example embodi through a pump having electrodes comprising cerium oxide according to a specific example embodiment of the disclo ment of the disclosure ; 15 sure ; FIG . 8D illustrates a sectional view of the pump system FIG . 16 illustrates a linear increase in flow with the shown in FIG . 8C in which the drug chamber is being filled applied voltage for a pump having electrodes comprising with an oil separator according to a specific example cerium oxide according to a specific example embodiment 
embodiment of the disclosure ; of the disclosure ; and 
FIG . 8E illustrates a sectional view of the pump system 20 FIG . 17 illustrates changes in current and flow in a pump 
shown in FIG . 8D in which the drug chamber is being filled having electrodes comprising cerium oxide operated at 
with a drug - containing fluid according to a specific example constant voltage and with non - boiled and freshly boiled 
embodiment of the disclosure ; water according to a specific example embodiment of the 
FIG . 9A illustrates an isometric view of a pump system disclosure . 
according to a specific example embodiment of the disclo - 25 
sure in which the water chamber is being filled with water ; DETAILED DESCRIPTION 
FIG . 9B illustrates an isometric view of the pump system 
shown in FIG . 9A in which the water - filled water chamber In some embodiments , the present disclosure relates , to a 
is being capped with oil according to a specific example pump ( e . g . , an electro - osmotic pump ) . For example , a direct 
embodiment of the disclosure ; 30 current ( DC ) electro - osmotic pump may comprise ( i ) a 
FIG . 9C illustrates an isometric view of the pump system porous cathode optionally comprising a lanthanide oxide or 
shown in FIG . 9B ( flipped over relative to FIG . 9B ) in which actinide oxide ( e . g . , cerium oxide ) , ( ii ) a porous anode 
the drug chamber is being filled with a water primer accord - optionally comprising a lanthanide oxide or actinide oxide 
ing to a specific example embodiment of the disclosure ; ( e . g . , cerium oxide ) , and ( iii ) a porous ceramic membrane 
FIG . 9D illustrates an isometric view of the pump system 35 between the cathode and the anode . In some embodiments , 
shown in FIG . 9C in which the drug chamber is being filled a porous cathode and / or a porous anode may be substantially 
with an oil divider according to a specific example embodi - metal free . 
ment of the disclosure ; Lanthanide oxide or actinide oxide ( e . g . , cerium oxide ) 
FIG . 9E illustrates an isometric view of the pump system may be of mixed valence , for example in the case of cerium 
shown in FIG . 9D in which the drug chamber is being filled 40 oxide it may comprise both Cet + and Ce3 + . The oxide may 
with a drug - containing fluid according to a specific example also comprise hydrogen , for example as bound water or as 
embodiment of the disclosure ; bound H + or as bound OH " , and it may also comprise bound 
FIG . 10A illustrates a sectional view of a pump system in oxygen , for example as bound 02 , bound superoxide radical 
which the water chamber and the drug chambers are loaded anion . 02 , bound superoxide radical . OOH , or bound 
and ready for use according to a specific example embodi - 45 hydrogen peroxide H , O , . A pump may further comprise , in 
ment of the disclosure ; some embodiments , ( a ) an aqueous liquid to be pumped 
FIG . 10B illustrates a sectional view of the pump system ( e . g . , in contact with the cathode , anode , and / or membrane ) , 
shown in FIG . 10A during operation according to a specific ( b ) a separator in fluid communication with the aqueous 
example embodiment of the disclosure ; liquid to be pumped and / or ( c ) a second liquid ( e . g . , com 
FIG . 10C illustrates a sectional view of the pump shown 50 prising a drug and / or an allergen ) in fluid communication 
in FIGS . 10A and 10B following operation according to a with the separator and separated from the aqueous fluid and 
specific example embodiment of the disclosure ; configured and arranged such that movement of the aqueous 
FIG . 11 illustrates a subject wearing a pump system liquid ( e . g . , by the action of the pump ) moves the separator , 
according to a specific example embodiment of the disclo - which in turn moves the second liquid . In some embodi 
sure ; 55 ments , at least a part of the surface of the membrane may be 
FIG . 12A illustrates a exploded view of a pump according in physical contact with the anode and / or at least a part of the 
to a specific example embodiment of the disclosure ; opposite side of the membrane may be in physical contact 
FIG . 12B illustrates the pump shown in FIG . 12A with the cathode . A porous ceramic membrane may com 
assembled according to a specific example embodiment of prise , according to some embodiments , silica or ceria 
the disclosure ; 60 spheres from about 0 . 1 um to about 10 um in diameter ( e . g . , 
FIG . 13A illustrates a generally isometric view of a pump from about 0 . 5 um in diameter to about 3 um in diameter ) . 
system according to a specific example embodiment of the In some embodiments , silica spheres may be selected from 
disclosure ; uncoated silica spheres , phosphosilicic - acid - coated silica 
FIG . 13B illustrates a generally isometric view of the spheres , borosilicic acid - coated silica spheres , and combi 
pump system shown in FIG . 13A in operation such that fluid 65 nations thereof . A silica microsphere may optionally be 
has begun to move through drug outlet according to a microporous in some embodiments . A silica may comprise , 
specific example embodiment of the disclosure ; according to some embodiments , metal ions ( e . g . , metal ions 
con 
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that may lower the glass transition temperature including , coated with the conductive composition comprising cerium 
without limitation , calcium and / or sodium ) . For example , a oxide nanoparticles . For example , a cathode and / or an anode 
silica may comprise a total concentration of sodium ions and may comprise carbon paper ( e . g . , plasma - treated carbon 
calcium ions of less than about 10 mole percent . paper ) without metal or substantially without metal . 
In some embodiments , a porous ceramic membrane may 5 The present disclosure also relates , in some embodiments , 
be from about 0 . 1 mm to about 3 mm thick and / or from to methods of pumping a liquid ( e . g . , an aqueous liquid ) . For 
about 1 mm to about 30 mm wide . In some embodiments , an example , a method may comprise contacting the liquid with 
electro - osmotic pump may comprise a layered composition . an electro - osmotic pump comprising ( i ) a cathode compris 
According to some embodiments a layered composition may ing carbon paper coated with a conductive composition 
comprise : ( i ) a first layer comprising a porous substrate and 10 comprising cerium oxide nanoparticles , ( ii ) an anode com 
a coating contacting at least a portion of the substrate ; ( ii ) a prising carbon paper coated with a conductive composition 
second layer comprising a porous silica matrix ; ( iii ) a third comprising cerium oxide nanoparticles , and ( iii ) a ceramic 
layer comprising a porous substrate and a coating contacting membrane formed by fusing uncoated or phosphosilicic 
at least a portion of the substrate . In some embodiments , the acid - coated fused ceramic ( e . g . , silica ) spheres ( e . g . , ran 
coating may comprise a lanthanide oxide or actinide oxide 15 domly packed between the cathode and the anode ) and / or 
( e . g . , cerium oxide ) . In some embodiments , at least a portion applying constant current to cause a potential difference 
of the first layer may be in contact with the second layer and between the anode and the cathode of from about 0 . 1 V to 
at least a portion of the third layer may be in contact with the about 3 V such that the aqueous liquid is pumped . According 
second layer . In some embodiments , a porous substrate of a to some embodiments , an aqueous liquid may be water ( e . g . , 
composition layer may comprise carbon ( e . g . , non - woven 20 deionized water ) . A liquid ( e . g . , an aqueous liquid ) may 
carbon paper or cloth ) . A layered composition may com comprise water containing a total solute ( e . g . , electrolyte ) 
prise , in some embodiments , a coating with at least 2 % by concentration of less than about 50 mM , less than about 10 
weight of cerium oxide , for example at least 5 % by weight , mM , less than about 5 mM , less than about 1 mM , less than 
or at least 10 % by weight or at least 20 % by weight or at about 0 . 1 mM . A pump may further comprise , in some 
least 30 % by weight or at least 50 % by weight cerium oxide . 25 embodiments , a separator ( e . g . , a fluid separator comprising 
A layered composition may also comprise a perfluorosulfo - air and / or an oil ) in fluid communication with an aqueous 
nic acid / polytetrafluoroethylene copolymer or a perfluoro - liquid to be pumped and a second liquid in fluid communi 
sulfonic acid / polytetrafluoroethylene copolymer ) . cation with the separator and separated from the aqueous 
The potential difference ( V ) between the anode and the fluid . A method may further comprise moving the aqueous 
cathode may be 0 . 1 volts < Vs3 volts at about 25° C . and / or 30 liquid such that the separator moves , which in turn moves 
the flow rate per cm ? of liquid - contacted area of the electro the second liquid . A second liquid may comprise , for 
osmotic pump may be at least 1 uL min - - cm - ? , for example , example , a drug ( e . g . , insulin , an antibiotic , and / or a biologic 
at least 5 uL min - 1 cm - 2 , for example , at least 10 uL min - 1 drug ) and / or an allergen . In some embodiments , applying 
cm - ? , for example , at least 20 uL min - cm - 2 according to current comprises applying a current , such that the current 
some embodiments . The flow rate of an electro - osmotic 35 density , based on the water - contacted , geometrical area of 
pump may vary , in some embodiments , about linearly ( e . g . , the electrodes is from about 0 . 01 mA cm - 2 to about 2 mA 
linearly ) with applied current and / or applied voltage . cm - 2 . The flow rate may vary , in some embodiments , about 
According to some embodiments , the volume of liquid linearly ( e . g . , linearly ) with applied current and / or applied 
pumped may be monitored , for example , coulometrically voltage . For example , the flow rate of an aqueous liquid may 
monitored . An anode , a cathode , or both an anode and a 40 vary about linearly ( e . g . , linearly ) with applied current 
cathode may comprise porous carbon ( e . g . , non - woven density from about 10 mL min A - cm - ? to about 700 mL 
carbon , woven carbon paper , or cloth ) , in some embodi min - | A - 1 cm - 2 . At any instant , the flow rate of the aqueous 
ments . An anode may be and / or may comprise a carbon liquid per unit cross sectional aqueous liquid contacted area 
mesh according to some embodiments . may be , in some embodiments , between about 10 uL min - 1 
The present disclosure also relates , in some embodiments , 45 cm - 2 and about 100 uL min - 1 cm - 2 . In some embodiments , 
to methods of producing a pump ( e . g . , an electro - osmotic applying constant current may produce substantially no 
pump ) . For example , a method may comprise adding an bubbles ( e . g . , no bubbles comprising hydrogen and / or oxy 
aqueous solution of H PO , and / or boric acid to a suspension gen ) . Application of constant current may comprise apply 
of silica microspheres ( e . g . , from about 1 um to about 3 um ing , according to some embodiments , two or more pulses . 
in diameter ) , evaporating the water from the resulting sus - 50 For example , in some embodiments the pulses may occur at 
pension to form a powder , pressing the powder to form a an interval of less than 10 minutes , 5 minutes , 2 minutes , 1 
pellet having at least two opposite surfaces , firing the pellet minute , and / or 30 seconds . 
( e . g . , for about 4 hours at from about 700° C . to about 900° According to some embodiments , a method of pumping a 
C . ) to form the ceramic membrane , and / or pressing two liquid ( e . g . , aqueous liquid ) may comprise contacting the 
carbon paper electrodes ( e . g . , a cathode and an anode ) , each 55 liquid with an electro - osmotic pump comprising ( i ) a cath 
electrode optionally coated with a composition comprising ode comprising carbon paper coated with a conductive 
cerium oxide nanocrystallites onto opposite surfaces of the composition comprising cerium oxide nanoparticles , ( ii ) an 
ceramic membrane to form an electrode - membrane - elec - anode comprising carbon paper coated with a conductive 
trode sandwich . In some embodiments , a method may composition comprising cerium oxide nanoparticles , and 
further comprise washing and / or drying the ceramic mem - 60 ( iii ) a ceramic membrane formed for example by fusing 
brane ( e . g . , after firing the pellet ) . A suspension of micro - uncoated or phosphosilicic - acid - coated fused ceramic ( e . g . , 
spheres may comprise one of mono - disperse microspheres silica ) spheres ( e . g . , randomly packed between the cathode 
and poly - disperse microspheres according to some embodi - and the anode ) and / or applying a constant potential differ 
ments . A method may further comprise , in some embodi - ence or voltage between the anode and the cathode of from 
ments , encapsulating the sandwich ( e . g . , encapsulating the 65 about 0 . 1 V to about 3 V such that the aqueous liquid is 
sandwich in epoxy ) . According to some embodiments , the pumped . According to some embodiments , an aqueous liq 
cathode and the anode may comprise carbon paper notuid may be water ( e . g . , deionized water ) . A liquid ( e . g . , an 
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aqueous liquid ) may comprise a solute at a concentration of fluid communication with the curvatures of the second fluid 
less than about 10 - 2 moles per liter in some embodiments . A chamber . According to some embodiments , an electro - os 
pump may further comprise , in some embodiments , a sepa - motic pump fluid reservoir may comprise two generally 
rator ( e . g . , a fluid separator comprising air and / or an oil ) in tubular fluid chambers with a chamber volume of from about 
fluid communication with an aqueous liquid to be pumped 5 0 . 2 mL to about 5 mL . The present disclosure also relates to 
and a second liquid in fluid communication with the sepa - an electro - osmotic fluid delivery system . In some embodi 
rator and separated from the aqueous fluid . A method may ments , an electro - osmotic fluid delivery system may com 
further comprise moving the aqueous liquid such that the prise an electro - osmotic pump , an electro - osmotic pump 
separator moves , which in turn moves the second liquid . A reservoir , a removable controller assembly and a cannula 
second liquid may comprise , for example , a drug ( e . g . , 10 and / or a needle in fluid communication with a delivery fluid 
insulin , an antibiotic , and / or a biologic drug ) and / or an chamber . According to some embodiments an electro - os 
allergen . In some embodiments a voltage from about 0 . 01 V motic pump may comprise ( i ) a porous cathode coated with 
to about 3 V , preferably from about 0 . 02 V and about 2 V , a conductive composition comprising cerium oxide nano 
for example between 0 . 5 V and 1 . 2 V is applied . In some particles , ( ii ) a porous anode coated with a conductive 
embodiments , applying constant potential difference or volt - 15 composition comprising cerium oxide nanoparticles , and 
age may produce substantially no bubbles ( e . g . , no bubbles ( iii ) a porous ceramic membrane between the cathode and 
comprising hydrogen and / or oxygen ) . Application of con the anode . In some embodiments , an electro - osmotic pump 
stant current may comprise applying , according to some reservoir may comprise a pump fluid chamber in fluid 
embodiments , two or more pulses . For example , in some communication with the electro - osmotic pump and a deliv 
embodiments the pulses may occur at an interval of less than 20 ery fluid chamber in fluid communication with the electro 
10 minutes , 5 minutes , 2 minutes , 1 minute , and / or 30 osmotic pump . In some embodiments , a removable control 
seconds . ler assembly may be in electrical communication with the 
The present disclosure also relates , in some embodiments , anode and the cathode . In some embodiments an electro 
to a device delivering fluids ( e . g . , solutions of drugs ) . For osmotic fluid delivery system may comprise a pump fluid 
example , a device may comprise a reservoir , a controller and 25 chamber comprising pump fluid proximal to a pump . In 
one or more sensors . According to some embodiments , an some embodiments , the delivery fluid chamber may com 
electro - osmotic pump fluid reservoir may comprise two prise pump fluid proximal to an electro - osmotic pump , a 
generally tubular fluid chambers from about 2 mm to about delivery fluid distal to the electro - osmotic pump and proxi 
10 mm in inside diameter . According to some embodiments , mal to a needle , and a separator positioned between the 
the interior surface of first , second or both of the fluid 30 pump fluid and the delivery fluid . In some embodiments , an 
chambers may comprise a hydrophobic coating . In some electro - osmotic fluid delivery system may comprise pump 
embodiments , the two generally tubular fluid chambers may fluid consisting essentially of water and a delivery fluid may 
comprise a first opening and at least one curvature having a comprise a pharmaceutically active ingredient , an allergen , 
concave edge . According to some embodiments , the first an antibody , and / or a nutrient . In some embodiments , an 
opening of the first fluid chamber may face and be spaced 35 electro - osmotic fluid delivery system may comprise a 
apart from the first opening of the second fluid chamber . In removable controller assembly comprising a user interface , 
some embodiments , an electro - osmotic pump fluid reservoir a processor , memory in electrical signal communication 
may comprise at least one curvature having a concave edge with the processor , and a power source in electrical com 
of the second fluid chamber that may be coplanar with and munication with the processor , and / or the memory . Accord 
proximal to the concave edge of the curvature of the first 40 ing to some embodiments , an electro - osmotic fluid delivery 
fluid chamber . In some embodiments , the first fluid chamber system controller assembly may comprise a user interface 
may be substantially in a first plane and the second fluid configured to permit the magnitude and / or duration of the 
chamber may be substantially in a second plane . In some current to be applied to a pump , the magnitude and / or 
embodiments , the first plane and second plane may be duration of the potential difference or voltage to be applied 
substantially parallel to each other and the first fluid cham - 45 to a pump , or both to be set and / or changed by a user . In 
ber may be substantially overlaying the second fluid cham - some embodiments , a user interface may comprise at least 
ber . According to some embodiments , the volume in the first one input key . According to some embodiments , an electro 
chamber may be smaller , greater or the same as the volume osmotic fluid delivery system may further comprise a trans 
in the second chamber . In some embodiments , a concave mitter and / or receiver in signal communication with a con 
edge of the at least one curvature of the first fluid chamber 50 troller , a pump , or a controller and a pump . In some 
and the concave edge of the at least one curvature of the embodiments , an electro - osmotic fluid delivery system may 
second fluid chamber of an electro - osmotic pump fluid comprise an adhesive pad and / or an elastic band fixed to the 
reservoir may partially define a well configured to receive a reservoir . According to some embodiments , an electro 
controller assembly . osmotic fluid delivery system may comprise a pump fluid 
According to some embodiments , a first generally tubular 55 chamber comprising an outer pump fluid chamber curvature 
fluid chamber of an electro - osmotic pump fluid reservoir comprising a concave edge , an inner pump fluid chamber 
may comprise one or more additional curvatures oriented in curvature having a concave edge concentric to and coplanar 
substantially the same plane as and concentrically with the with the concave edge of the outer pump fluid chamber 
first curvature and additional curvatures of the first fluid curvature , and a hairpin turn in fluid communication with the 
chamber , and one or more hairpin turns positioned between 60 outer and inner pump fluid chamber curvatures . In some 
and in fluid communication with the curvatures of the first embodiments , the delivery fluid chamber may comprise an 
fluid chamber . In some embodiments , second generally outer delivery fluid chamber curvature having a concave 
tubular fluid chamber of an electro - osmotic pump fluid edge , an inner delivery fluid chamber curvature having a 
reservoir may comprise one or more additional curvatures concave edge concentric to and coplanar with the concave 
oriented in substantially the same plane as and concentri - 65 edge of the outer delivery fluid chamber curvature , and a 
cally with the first curvature of the second fluid chamber , hairpin turn in fluid communication with the outer and inner 
and one or more hairpin turns positioned between and in delivery fluid chamber curvatures . According to some 
13 
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embodiments , a pump fluid chamber and a delivery fluid example , smaller than about 10 cm " , and for example , 
chamber at least partially encircle a removable controller smaller than about 5 cm " . In some embodiments of the 
assembly . present disclosure , the reservoir may contain a sufficient 
The present disclosure also relates to a method of deliv - volume of a fluid ( e . g . , drug solution or dispersion ) for 
ering a fluid to a subject . For example , a method may 5 delivery over about a 1 - 10 - day period ( e . g . , about a 2 - 3 day 
comprise ( i ) providing an electro - osmotic drug delivery period ) . 
system comprising a reservoir , a removable controller and a Pump Membranes 
needle and / or a cannula in fluid communication with the According to some embodiments a pump may comprise a 
delivery fluid chamber , ( ii ) inserting the needle and / or membrane ( e . g . , a porous membrane ) and two or more 
cannula into a subject ; and ( iii ) applying a constant potential 10 electrodes . For example , a pump may be configured as an 
difference or constant current between the anode and cath - electro - osmotic pump and comprise a membrane ( e . g . , a 
ode . porous membrane ) , a cathode at least a portion of which is 
In some embodiments , an electro - osmotic pump may in contact with the membrane , and an anode at least a portion 
comprise ( i ) a porous cathode coated with a conductive of which is in contact with the membrane . A membrane ( e . g . , 
composition comprising cerium oxide nanoparticles , ( ii ) a 15 a porous membrane ) may have any desired or required shape 
porous anode coated with a conductive composition com - and / or size . According to some embodiments , a membrane 
prising cerium oxide nanoparticles , and ( iii ) a porous ( e . g . , a porous membrane ) may have a generally circular 
ceramic membrane between and in at physical contact with shape with a circumference and two opposing surfaces . A 
the cathode and the anode . In some embodiments , an elec - membrane ( e . g . , a porous membrane ) may have a diameter 
tro - osmotic reservoir may comprise a pump fluid chamber 20 less than , 8 mm , for example less than 6 mm , for example 
and a delivery fluid chamber in fluid communication with less than 1 . 3 mm . A membrane may have a thickness less 
the electro - osmotic pump . In some embodiments , a pump than 3 mm , for example less than 2 mm , for example , less 
fluid chamber may comprise a first aliquot of pump fluid than 1 . 3 mm . The porous membrane can be ceramic ; it may 
proximal to the electro - osmotic pump . In some embodi - comprise , for example silica or ceria . A membrane ( e . g . , a 
ments , a delivery fluid chamber may comprise a second 25 porous membrane ) may comprise , for example , mono - dis 
aliquot of pump fluid proximal to a pump , a delivery fluid perse or polydisperse silica microparticles with diameters of 
positioned distal to the electro - osmotic pump , and a sepa - less than about 10 um , for example , less than about 10 um , 
rator positioned between the second aliquot of pump fluid for example , less than about 5 um , for example , less than 
and the delivery fluid . In some embodiments , a removable about 2 um , for example , less than about 1 um , for example , 
controller may be in electrical communication with an anode 30 less than about 0 . 5 um , for example , less than about 0 . 2 um . 
and a cathode . In some embodiments , application of a A membrane ( e . g . , a porous membrane ) may comprise , in 
constant potential difference or a constant voltage may some embodiments , a porous ceramic or a polymeric organic 
comprise moving a volume of a first aliquot of pump fluid material having anionic or cationic functions . A membrane 
from a pump fluid chamber across a porous membrane to a may have a polyanionic surface . Examples of useful porous 
delivery fluid chamber to commensurately increase the 35 ceramic materials include silica , ceria , cerium phosphate , 
volume of the second aliquot of pump fluid in the delivery zirconia , titania , alumina , zirconium phosphate , zirconium 
fluid chamber and through a needle and / or cannula into a silicate , phosphosilicate glass , borosilicate glass . Optionally , 
subject . In some embodiments , the volume of delivery fluid a membrane may be formed by heating microspheres of a 
passing through a needle into a subject may be substantially ceramic , for example , heating fused silica microspheres with 
the same as the increased volume of the second aliquot of 40 phosphoric or polyphosphoric acid . Examples of polymeric 
pump fluid in the delivery fluid chamber . In some embodi - organic membranes include cation exchangers like 
ments , a pump fluid may consist essentially of deionized NAFION® ( a perfluorosulfonic acid / polytetrafluoroethyl 
water . In some embodiments , a delivery fluid may comprise ene copolymer ) , sulfonated polystyrene and its co - polymers . 
insulin , an antibiotic , a biologic drug , and / or allergen . In some embodiments , a membrane may be formed by 
According to some embodiments , the flow rate of a pump 45 pelletizing at 300 psi then firing phosphosilicic acid coated 
fluid may vary linearly with voltage . At any instant the flow 1 um mono - disperse silica microspheres at 700° C . for 4 h . 
rate of a pump fluid per unit cross sectional pump fluid - A membrane may be sandwiched between an anode and a 
contacted area may be between about 1 uL min - cm and cathode , each of which is coated with a conductive compo 
about 1 mL min - 1 cm - 2 , for example , between about 10 ul sition comprising cerium oxide nanoparticles . According to 
min - cm - 2 and about 100 UL min - cm - 2 . Applying con - 50 some embodiments , a membrane may be made of porous 
stant potential difference or constant voltage may produce silica that has an optional phosphosilicic acid and / or boro 
substantially no bubbles according to some embodiments . silicic acid shell . Optionally , a silica may be microporous . A 
The present disclosure relates , in some embodiments , to microporous silica may have pores with a diameter of , for 
methods , devices , and systems for delivering a composition example , less than about 5 um or less than about 100 nm . A 
( e . g . , a fluid composition ) to a subject ( e . g . , human and / or 55 silica may , in some embodiments , comprise a metal oxide 
non - human animal ) . For example , delivering a composition ( e . g . , Na , O , CaO ) . For example , a silica may comprise a 
( e . g . , a fluid composition ) to a subject may comprise sub - mole percent of Na2O , CaO , or Na2O + CaO of from about 1 
cutaneous or other in - tissue delivering ( e . g . , pumping ) of mole percent to about 5 mole percent , from about 5 mole 
dissolved or solution - dispersed therapeutic drugs . Some percent to about 10 mole percent , and / or from about 10 mole 
pumps of the present disclosure may be of the type that 60 percent to about 20 mole percent . A membrane may be 
deliver insulin stored in a remote reservoir fluidically con - formed , according to some embodiments , by fusing a phos 
nected ( e . g . , by tubing ) to a cannula . Delivery may be phosilicic acid coating or a borosilicic acid coating onto 
accomplished by putting a pump in fluid communication fused silica spheres of 1 um diameter . In some embodiments , 
with one or more tissues in a subject . For example , a pump a membrane may comprise ceria ( CeO2 ) or zirconia ( ZrO2 ) 
may be in a system that is skin mounted or attached with its 65 reacted with a phosphorus and oxygen containing com 
cannula connected by a short tubing . In some embodiments , pound , such as phosphoric acid or a polyphosphoric acid or 
the volume of the unit may be smaller than about 15 cm° , for phosphorus pentoxide , optionally to form a phosphated ceria 
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or zirconia surface , such as a Cez ( PO4 ) 4 or Zr3 ( PO4 ) 4 difference results in a reaction by which H + and / or OH 
enriched surface . The zirconia may be stabilized , for move across and / or through a membrane according to some 
example , with yttria , calcium ( “ calcia ” ) , or other suitable embodiments . For example , it may be desirable to select a 
stabilizers . A membrane may comprise , according to some composition such that protons ( H + ) move across and / or 
embodiments , alumina ( Al2O3 ) reacted with a phosphorus 5 through a membrane . Electrodes , ( e . g . , the anode and cath 
and oxygen containing compound , such as phosphoric acid ode ) , according to some embodiments , may be porous . In or a polyphosphoric acid or phosphorus pentoxide , option some embodiments an anode may comprise carbon , for ally to form a phosphated alumina surface . In some embodi example , woven or non - woven carbon cloth or paper , or ments , a membrane may comprise glass , such as soda lime carbon foam . One example of a carbon cloth electrode is glass or borosilicate glass or lead glass , reacted with a 10 TGP - H - 030 , made by Toray Industries Inc . , 2 - 1 , Nihon phosphorus and oxygen containing compound , such as phos bashi - Muromachi 2 Chome , Chuo - ku , Tokyo , Japan . A phoric acid or a polyphosphoric acid or phosphorus pentox porous carbon anode may be coated ( e . g . , advantageously ide , optionally to form a phosphated glass surface . In some 
coated ) with , for example , colloidal tin oxide , sold , for embodiments , a membrane may comprise a polyvinyl phos 
phonate polymer or co - polymer membranes , which may be 15 example , as a NYACOL® SN15 dispersion by Nyacol Nano 
made water - insoluble by crosslinking or according to other Technologies Inc . , Ashland , Mass . For example , an anode 
known methods . may be , for example , dip - coated , and / or spray - coated with a 
In some embodiments , a porous membrane may comprise NYACOL® SN15 dispersion . In some embodiments , an 
vitreous and / or crystalline ceramics , or mixed vitreous and anode may be coated with a ceria sol , for example , colloidal 
crystalline oxides comprising , at least in their water or other 20 ceria , sold by NYACOL® Nano Technologies Inc . , Ashland , 
fluid contacting surface , phosphorus ( e . g . , in the five - valent Mass . , either with nitrate counter - ions or with acetate coun 
oxidation state ) and / or boron ( e . g . , in the five - valent oxida ter - ions , the ceria particle sizes being in the sol according to 
tion state ) . Examples of membrane materials include phos - the manufacturer 10 - 20 nM . A carbon electrode may be first 
phosilicic acid and / or phosphosilicate glass on fused silica ; coated with colloidal tin oxide , then with colloidal ceria , 
borosilicic acid on fused silica ; zirconia ( Zro ) or ceria 25 according to some embodiments . 
( CeO2 ) reacted with a phosphorus and oxygen containing In some embodiments , a porous cathode may be carbon 
compound , such as phosphoric acid or a polyphosphoric based . For example , a cathode may be woven or non - woven 
acid or phosphorus pentoxide , optionally to form a phos carbon cloth or paper , or carbon foam . A carbon - based , 
phated zirconia surface , such as a Zr ( PO ) , or Cez ( POA ) . porous cathode , according to some embodiments , may be 
enriched surface , with the zirconia optionally phase - stabi - 30 made hydrophilic . For example , it may be desirable or 
lized , for example , with yttria or with calcium oxide ; or necessary to make a carbon - based , porous cathode ( e . g . , a 
alumina ( A1203 ) reacted with a phosphorus and oxygen woven or non - woven carbon cloth or paper or a carbon 
containing compound , such as phosphoric acid or a poly - foam ) hydrophilic by exposure to a plasma ( e . g . , an about 20 
phosphoric acid or phosphorus pentoxide , optionally to form torr oxygen plasma for about an hour ) . 
a phosphated alumina surface ; or a glass , such as soda lime 35 According to some embodiments , it may be desirable , 
glass , or a borosilicate glass or a lead glass , reacted with a preferred , and / or required to use electrodes comprising a 
phosphorus and oxygen containing compound , such as phos - conductive composition comprising cerium oxide nanopar 
phoric acid or a polyphosphoric acid or phosphorus pentox - ticles . An electrode may comprise enough of a conductive 
ide , optionally to form a phosphated glass surface . A phos composition comprising cerium oxide nanoparticles to have 
phosilicate glass and / or a borosilicate glass may be used , the 40 a coulombic capacity of at least 2 millicoulombs ( mC ) , at 
surface of which may be optionally phosphorous - oxide least 10mC , at least 20 mC , at 100 mC , at least 0 . 2 C , at least 
enriched and / or boron oxide enriched . Porous metal phos - 0 . 5 C ; or at least 1 C . In some embodiments , the conductivity 
phates such as AIPO4 , Zr3 ( PO4 ) 4 , Cez ( PO4 ) 4 , Zn3 ( PO4 ) 4 or of the cerium oxide nanocrystallytes comprising coatings of 
FePO4 or Fe3 ( PO4 ) 2 may be used in some embodiments . the electrodes can be increased by incorporating carbon in 
Packing of fused spheres , according to some embodiments , 45 the coatings . 
may be random , haphazard , and / or incompletely ordered . Each electrode may independently comprise a plasma 
According to some embodiments , a microsphere may treated carbon paper with or without a metallic conductive 
have a diameter ( e . g . , an average diameter ) of less than material , according to some embodiments . For example , it 
about 10 um ( e . g . , less than about 10 um , less than about 5 may be desirable and / or required to use electrodes that do 
um , less than about 2 um , less than about 1 um , less than 50 not include cerium oxide nanoparticles . In some embodi 
about 0 . 5 um , less than about 0 . 2 um , and / or less than about ments , electrodes ( e . g . , a cathode , an anode , or both a 
0 . 1 um ) . cathode and an anode ) may be substantially free ( e . g . , free ) 
In accordance with exemplary embodiments and to of metal . Non - metallic conductive materials may confer 
remove any unbound phosphoric acid resulting from the electrode operability , according to some embodiments . Non 
above process , the about 0 . 8 cm outer diameter ceramic 55 metallic conductive materials may comprise , for example , 
membranes may be washed with copious amounts of water . carbon , carbon paper , woven carbon paper , non - woven 
After assembly of the membranes in the sandwiches shown carbon paper , plasma - treated carbon paper , carbon fiber , 
in FIG . 5 , they may be washed again for about 25 min at polyacetylene , polypyrrole , and polyaniline , and combina 
about 10 uL min - 1 flow rate . The washing - water may come tions thereof . In some embodiments , a pump may comprise 
from a commercially - available syringe pump or other suit - 60 a porous , substantially metal - free anode comprising plasma 
able apparatus . treated carbon paper and a porous , substantially metal - free 
Pump Electrodes cathode comprising plasma - treated carbon paper . Without 
A potential difference ( i . e . , a voltage ) and / or a current limiting any embodiment to any specific mechanism of 
may be applied across the membrane through electrically action , plasma treatment may form electrooxidizable and / or 
conductive materials ( e . g . , electrodes ) positioned on oppo - 65 electroreducable groups on carbon surfaces . For example , 
site sides . The composition of electrically conductive mate - plasma treatment may produce a carbon surface comprising 
rials may be selected such that the application of a potential one or more conjugated groups . Conjugated groups may 
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include one or more phenols ( e . g . , diphenols ) and / or one or than about 0 . 03 cm , for example , greater than about 0 . 05 cm 
more carbonyls ( e . g . , quinones ) . and less than about 0 . 2 cm ; the water exposed area may be 
Substantially metal - free electrodes and / or substantially about 25 cm ? or less , for example , about 10 cm ? or less , for 
silver - free electrodes comprising cerium oxide may provide example , about 4 cm ? or less , for example , about 1 cm ? or 
durability , stability of flow - rate , reproducibility of flow - rate , 5 less , for example , 0 . 5 cm ? or less , for example , about 0 . 3 
controllability of flow , and / or combinations thereof . In some cm ? or less , for example , about 0 . 1 cm ? or less , for example , 
embodiments , an electrode may be substantially free of a about 0 . 05 cm ? or less . After assembly of the membranes in 
metal ( e . g . , a specific metal , specific metals , or all metals ) the sandwiches , they may be washed again for about 25 min 
even if it contains a trace of the metal ( e . g . , an amount at about 10 uL min - flow rate . The washing - water may 
insufficient to alone support electro - osmotic flow ) . 10 come from a commercially - available syringe pump or other 
The desired porosity of an electrode may be achieved , for suitable apparatus . 
example , by using a porous substrate ( e . g . , a porous , con In some embodiments an electrode may be in close 
ductive , and optionally non - corroding substrate ) , that need physical contact with the membrane , meaning that there is 
not be electrochemically reactive . Some useful electrode little or no aqueous liquid ( e . g . , free - flowing aqueous liquid ) 
materials , according to some embodiments , include forms of 15 separating either electrode from the membrane . In some 
porous carbon for example woven or non - woven carbon embodiments , means for good physical contact may include 
cloth or carbon paper or gold mesh or silver mesh . Anodes an electrochemically non - reactive thin film ( e . g . , a thin film 
may generate , in some embodiments , protons in their opera - of an electron and / or hole conductor ) deposited on both 
tion . According to some embodiments , cathodes may gen - sides of the membrane . A non - reactive conductive film may 
erate in their reaction hydroxide anions and / or may consume 20 comprise , for example , carbon or gold . The film may be 
protons in their operations . preferably thin enough to be porous in some embodiments . 
An electrode may have any desired or required shape The film may be deposited , for example , by sputtering or 
and / or size . According to some embodiments , an electrode evaporation or it could be painted or sprayed . Available 
( e . g . , a porous electrode ) may have a generally circular carbon pastes such as SPI carbon # 5065 or carbons available 
shape with a circumference and two opposing surfaces . In 25 from Timcal , Westlake Ohio , such as Timcal Super P car 
some embodiments , an electrode ( e . g . , a porous electrode ) bons may be used . In some embodiments , physical contact 
may have a similar or the same size and shape as its adjacent may be improved by polishing flat a ceramic membrane 
membrane . An electrode ( e . g . , a porous electrode ) may have before pressing onto it the electrochemically reactive com 
a diameter less than about 8 mm , less than about 6 mm , ponent containing carbon paper electrodes . In some embodi 
and / or less than about 1 . 3 mm . An electrode ( e . g . , a porous 30 ments , carbon paper may be hot - pressed onto the two sides 
electrode ) may have a diameter about 5 cm or less , about 2 of a ceramic membrane at a temperature typically exceeding 
cm or less , about 1 cm or less , and / or about 6 mm or less about 500° C . , for example , exceeding about 600° C . , for 
An electrode ( e . g . , a porous electrode ) may have a thickness example , exceeding about 700° C . , for example , exceeding 
less than about 3 mm , for example less than about 2 mm , for about 800° C . , for example , exceeding about 900° C . , for 
example , less than about 1 . 3 mm . In some embodiments , the 35 example , exceeding about 1000° C . , at a pressure typically 
outer diameter of an electrode - membrane - electrode sand - exceeding about 0 . 1 MPa , for example , exceeding about 0 . 2 
wich may be less than about 5 cm and more than about 0 . 1 MPa , for example , exceeding about 0 . 5 MPa , for example , 
cm ; for example , less than about 3 cm and more than about exceeding about 1 . 0 MPa , for example , exceeding about 2 
0 . 3 cm ; for example , less than 1 cm and more than 0 . 4 cm . MPa . 
In some embodiments , electrodes may be formed of 40 In some embodiments , the membrane could be dipped in 
materials that satisfy the following conditions : ( 1 ) non - a solution containing a gold complex like AuCl . - or 
gassing electrode reactions ( e . g . , no hydrogen evolved at Au ( CN ) , of which gold or platinum could be precipitated by 
cathode and no oxygen evolved at anode ) ; and / or ( 2 ) anode a reductant such as a reductant used in electroless plating of 
reaction generates protons and / or metal cations and cathode gold . In some embodiments , examples of reductants include 
reaction consumes protons and / or metal cations . 45 borohydrides and hypophosphites . In some embodiments , a 
According to some embodiments , DC electro - osmotic ceramic membrane may be coated by an electrode - forming 
pumps with anodes that do not evolve gaseous oxygen paste on its two sides . According to some embodiments , a 
and / or cathodes that do not evolve gaseous hydrogen may be compartment containing a pump fluid ( e . g . , pumped water or 
desired and / or preferred . Anodes ( e . g . , preferred anodes ) aqueous solution ) , and also a compartment containing a 
may generate , in some embodiments , protons and / or metal 50 delivery fluid ( e . g . , a drug solution or suspension ) may be 
cations in their operation . In some embodiments , anodes made , for example , by molding a plastic . Either or both 
may generate protons and / or metal cations in their operation . compartments may have a port or septum , such as a septum 
According to some embodiments , cathodes may generate in made of an elastomer , to allow their filling with water or 
their reaction hydroxide anions and / or may consume protons aqueous solution or with a drug solution or suspension . 
and / or metal cations in their operations . 55 Filling could be done , for example , with a syringe . Either or 
Pumps both compartments may have a hydrophobic vent allowing 
In some embodiments components of a pump may be air or other gases to escape , for example during filling . A 
simple and inexpensive . In some embodiments , total cost of vent may optionally comprise a hydrophobic porous mate 
pump components may be less than $ 2 . 00 , for example rial , to allow the escape of gases without allowing leakage 
$ 1 . 00 ( in 2011 USD ) . Components of a pump may comprise , 60 of the water or aqueous solution or of the drug suspension 
a pair of PVC receptacles , a pair of contact strips ( e . g . , thin or solution . Examples of hydrophobic porous vent materials 
gold foil or nickel ) a pair of coated carbon paper electrodes , include but are not limited to hydrophobic gas diffusion 
a ceramic membrane , and silicon tubing . The components of membranes optionally made of woven and non - woven 
a pump may be assembled by sandwiching a membrane fibrous perfluorinated polymers , exemplified by materials 
between electrodes . In some embodiments , the diameter of 65 used in zinc air batteries , such as the ExcelleratorTM PTFE 
the membrane and electrodes is 8 mm . In some embodi - Gas Diffusion Membrane of W . L . Gore & Associates of 
ments , the covered rim is less than about 0 . 3 cm and more Newark , Del . 
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Optionally , a drug - containing compartment may contain a FIG . 3B illustrates an assembled pump according to a 
drug concentrate in a non - aqueous solution or dispersion , or specific example embodiment of the disclosure . From left to 
a solid comprising the drug ( e . g . , for longer shelf life ) . In right , the components are : silicon tubing 335 , PVC frame 
this case the drug solution or suspension is prepared prior to 334 , gold strip 333 , carbon paper anode 330 coated with a 
use , for example by adding water or an aqueous solution to 5 composition comprising cerium oxide nanocrystallites , 
the drug containing compartment prior to use . This may be ceramic membrane 320 , carbon paper cathode 340 coated 
preferred , for example , when the delivered drug is glucagon , with a composition comprising cerium oxide nanocrystal 
available from Eli Lilly & Co . Indianapolis , Ind . , because lites , gold strip 343 , PVC frame 344 , silicon tubing 345 . The 
the shelf life of its typically injected solution is usually only sandwiches may be encapsulated in an epoxy , with foil lips 
of about a day . 10 ( e . g . , gold foil lips ) ( 333 , 343 ) inserted between the mem 
In some embodiments , a nanocrystalline cerium oxide brane 320 and the electrodes 330 , 340 for electrical con 
comprising anode and a cathode may be reversible and tacting . An assembled electrode - membrane - electrode sand 
identical except for their local pH difference . Little , if any , wich may be washed with water from a syringe pump ( e . g . , 
oxygen may be evolved for example if Ce3 + is electrooxi - Cole Parmer 780100C , Vernon Hills , 111 . ) for 25 min at 10 uL 
dized to Ce + + at the anode , and no hydrogen is evolved if , 15 min flow rate before use . 
for example , Ce + + is electroreduced to Ce + at the cathode , Reservoirs 
or , for example , if cerium oxide bound oxygen is electrore - An assembled pump may be inserted into a gap of a 
duced at the cathode and is electro - generated at the anode . reservoir assembly . According to some embodiments , a 
FIG . 1 illustrates a sectional view of the structure of pump reservoir assembly may comprise two compartments . In 
110 according to a specific example embodiment of the 20 some embodiments , one compartment may contain pumped 
disclosure . Pump 110 comprises a SiO , membrane 120 , water or aqueous solution , and a second compartment may 
comprising silica spheres 121 , sandwiched between elec - contain a drug solution or of a solution containing multiple 
trodes 130 and 140 . Electrodes 130 and 140 each comprise drugs , stored in a reservoir suspension . In some embodi 
a carbon paper substrate ( 131 and 141 , respectively ) covered ments , a reservoir may be made , for example , by molding a 
with the coating comprising cerium oxide nanocrystallites 25 plastic . In some embodiments , either or both compartments 
and optionally also carbon and / or Nafion 132 . In some may have a port or septum , such as a septum made of an 
embodiments , electrodes 130 and 140 may each comprise a elastomer , to allow their filling with the water or aqueous 
carbon paper substrate ( 131 and 141 , respectively ) that are solution or with the drug solution or suspension . According 
not covered with the coating comprising cerium oxide to some embodiments , a reservoir assembly may have any 
nanocrystallites , but are substantially metal free . The 1 . 3 30 desirable geometric configuration . Similarly , fluid chambers 
mm thick 8 mm diameter membrane may be formed by in a reservoir assembly may have , in some embodiments , 
fusing phosphosilicic acid coated silica microspheres . Flow - any desired configuration . A reservoir assembly , for 
through anode 130 and cathode 140 may be 280 um thick example , may have an annular shape . In some embodiments , 
78 % porosity carbon paper coated with the composition an annular reservoir assembly may comprise a gap ( e . g . , for 
comprising cerium oxide nanocrystallites . 35 insertion of a pump ) occupying a portion ( e . g . , less than 
FIG . 2 illustrates a sectional view of pump 210 , with about 20 % , less than about 10 % , less than about 5 % , and / or 
example electrode reactions , and transport processes accord - less than about 3 % of the annular circumference . A reser 
ing to a specific example embodiment of the disclosure . One voir assembly may be filled , for example , with a syringe . In 
or more other ( e . g . , alternate ) reactions may take place , some embodiments , either or both compartments may also 
according to some embodiments , including , for example , 40 have a hydrophobic vent allowing air or other gases to 
reactions involving O , bound to ceria , superoxide bound to escape , for example during loading and / or operation . A vent 
ceria , and / or hydrogen perozide . Pump 210 includes a pair m ay optionally comprise a hydrophobic porous material , to 
of identical , porous cerium oxide ( i . e . , Ce0 ) electrodes allow the escape of gases without allowing leakage of the 
230 and 240 , each of which comprises a carbon paper water or aqueous solution or of a drug suspension or 
substrate ( 231 and 241 , respectively covered with a coating 45 solution . Examples of hydrophobic porous vent materials 
comprising a cerium oxide ( 232 and 242 , respectively ) , include , but are not limited to , hydrophobic gas diffusion 
sandwiching ceramic membrane 220 . In some embodiments , membranes optionally made of woven and non - woven 
electrodes 230 and 240 may include carbon paper substrates fibrous perfluorinated polymers , exemplified by materials 
231 and 241 , respectively , but exclude cerium oxide coat - used in zinc air batteries , such as the ExcelleratorTM PTFE 
ings . The electrochemically reactive component of porous 50 Gas Diffusion Membrane of W . L . Gore & Associates of 
anode 230 or cathode 240 may be applied by any method . Newark , Del . Venting air and / or other gases may reduce 
FIG . 2 illustrates that application of current ( or voltage ) and / or prevent an undesirable pressure change in one or 
across the anode 230 and cathode 240 may drive protons , more chambers according to some embodiments . For 
produced in the anodic reaction Ce + + H2O - Ce ( OH ) 3 + + example , heat ( e . g . , body heat , sunlight , and / or others ) may 
H * + e , to the cathode , where they are consumed by the 55 lead to an increase in pressure that , if unchecked , may lead 
cathodic reaction Ce ( OH ) 3 + + H + + e - Ce3 + + H , O , the H2O to an unplanned change in flow rate . This , in turn , may lead 
optionally hydrating the Ce3 + ions . to over - dosing or under - dosing of a drug or other material in 
FIG . 3A illustrates an exploded view of a pump according a delivery fluid . 
to a specific example embodiment of the disclosure . FIG . 3 One or more reservoir surfaces ( e . g . , surfaces that contact 
depicts the low - cost components of a pump . From left to 60 a pump fluid , a separator , and / or a delivery fluid ) may be 
right , the components are : silicon tubing 335 , PVC frame hydrophobic according to some embodiments . For example , 
334 , gold strip 333 , carbon paper anode 330 coated with a a reservoir surface may be hydrophobic due to its intrinsic 
composition comprising cerium oxide nanocrystallites , composition , chemical treatment , and / or application of a 
ceramic membrane 320 , carbon paper cathode 340 coated hydrophobic coating ( e . g . , a long - chain alkyl trialkoxysi 
with a composition comprising cerium oxide nanocrystal - 65 lane ) . 
lites , gold strip 343 , PVC Frame 344 , silicon tubing 345 . The In some embodiments , a delivery fluid - containing com 
estimated cost of the depicted pump is $ 1 . 00 ( in 2011 USD ) . partment may contain an active pharmaceutical ingredient 
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( e . g . , a drug ) concentrate in a non - aqueous solution or embodiment of the disclosure . From left to right , the com 
dispersion , or a solid comprising the active pharmaceutical ponents are : PVC O - ring 534 , gold strip 533 , Ag / Ag20 
ingredient ( e . g . , for longer shelf life ) . In some embodiments , coated carbon paper anode 530 , ceramic membrane 520 , 
an active pharmaceutical ingredient solution or suspension Ag / Ag2O - coated carbon paper cathode 540 , gold strip 543 
may be prepared prior to use , for example by adding water 5 and PVC O - ring 544 . 
or an aqueous solution to the drug containing compartment In some embodiments , assembled components of a pump 
prior to use . This may be desirable , for example , when the system may be inserted into a reservoir gap . In some 
delivered active pharmaceutical ingredient is glucagon , embodiments , a reservoir may contain a chamber for 
available from Eli Lilly & Co . Indianapolis , Ind . , because pumped water and a chamber for a delivery fluid . As 
the shelf life of its typically injected solution is usually only 10 displayed in FIGS . 4A - D , delivery fluid reservoir volumes 
about a day . may vary for use with a pump and a system described herein . 
According to some embodiments , a pump may comprise In some embodiments , a system may comprise a reservoir 
means for metering ( e . g . , accurately metering ) a fluid , means with one or more hairpins . 
for pumping a fluid , and / or an implanted cannula . An FIG . 5B illustrates a plan view of the reservoir system 
implanted cannula may be connected , for example , through 15 according to a specific example embodiment of the disclo 
plastic tubing to a flow - causing pump , which pumps or sure . FIG . 5B depicts a reservoir 550 for pumped water and 
delivers a defined volume of a drug containing solution , or drug chambers and a pump gap . 
of a solution containing multiple drugs , stored in a reservoir . In some embodiments , a pump system ( e . g . , a functional 
In some embodiments , drug reservoir volumes may be drug infusion system ) may comprise a reservoir with two 
varied by increasing the thickness and / or length of the 20 chambers . In some embodiments , a reservoir may comprise 
reservoir . It may be desirable to increase reservoir volume a pump fluid chamber and a delivery fluid chamber . In some 
by increasing chamber length , for example , in reservoirs that embodiments , each chamber may comprise an opening , a 
may be used in skin - adhered embodiments . In some embodi - curved section , fluidly linked to a straight section , fluidly 
ments , reservoir volumes scale with the cube of their linear connected to a curved section , fluidly connected to a hairpin , 
dimensions . In some embodiments , a skin adhered system 25 fluidly connected to a curved section fluidly connected to a 
may be less than 12 mm OD . In some embodiments , straight section and fluidly connected to a curved section . In 
dimensions and drug solution reservoir volumes for a system some embodiments , a pump fluid chamber may comprise of 
of 8 mm thickness are 36x30x8 mm , 1 . 0 mL ; 53x47x8 mm , a proximal end , medial end , and distal end . In some embodi 
2 . 7 mL ; 78x72x8 mm , 7 . 0 mL . In some embodiments , ments , a pump fluid chamber may comprise of a pump 
dimensions and drug solution reservoir volumes for a system 30 coupling . In some embodiments , a reservoir may comprise 
of 12 mm thickness may have a volume of 20 mL for a a pump fluid chamber assembly comprising an air inlet . In 
78x72x12 mm system . some embodiments , a reservoir may comprise a pump fluid 
FIG . 4A illustrates reservoir assembly 450 gap 455 , pump chamber assembly comprising a pump fluid chamber fill 
fluid chamber 460 and delivery fluid chamber 480 . An inlet and septum . In some embodiments , a reservoir may 
assembled pump ( e . g . , as shown in FIG . 3B ) may be inserted 35 comprise a pump fluid chamber assembly comprising pump 
into gap 455 . FIG . 4B illustrates a plan view of a reservoir fluid chamber distal fill inlet . In some embodiments , a pump 
assembly 450 having a delivery fluid volume of 0 . 9 mL . A fluid chamber may comprise of a proximal end , medial end , 
reservoir assembly 450 comprises pump fluid chamber 460 and distal end . In some embodiments , a pump fluid chamber 
and delivery fluid chamber 480 . Pump fluid chamber com - may comprise a pump coupling . In some embodiments , a 
prises curvature 471a fluidly connected to straight section 40 reservoir may comprise a delivery fluid chamber assembly 
472a , fluidly connected to curvature 473a , fluidly connected comprising an air inlet . In some embodiments , a reservoir 
by hairpin a 474a to curvature 473b , fluidly connected to may comprise a delivery fluid chamber assembly comprising 
straight section 472b , fluidly connected to curvature 471b . a delivery fluid chamber fill inlet and septum . In some 
FIG . 4C illustrates a reservoir assembly having a delivery embodiments , a reservoir may comprise a delivery fluid 
volume of 2 . 7 mL . The pump fluid chamber comprises 45 chamber assembly comprising a pump fluid fill inlet and 
curvature 471a , fluidly connected to straight section 472a , septum . In some embodiments , a reservoir may comprise a 
fluidly connected to a curvature 473a , fluidly connected to delivery fluid chamber assembly comprising a delivery fluid 
straight section 472a , fluidly connected to a curvature 473d , outlet . In some embodiments , a delivery fluid chamber may 
fluidly connected to a straight section 472d , fluidly con comprise a proximal end , medial end , and distal end . In 
nected to a curvature 471d , fluidly connected to hairpin 50 some embodiments , a delivery fluid chamber may comprise 
474c , fluidly connected to a curvature 471c , fluidly con - a pump coupling . A reservoir assembly may comprise , in 
nected to straight section 472c , fluidly connected to hairpin some embodiments , a housing . A housing ( e . g . , a rigid 
474b , fluidly connected to curvature 473b , fluidly connected and / or semi - rigid housing ) may , for example , comprise any 
to straight section 472b , fluidly connected to curvature 471b , suitable plastics , polymers , acrylics , and / or other materials . 
fluidly connected to an air vent . 55 A housing may be transparent and / or or opaque in some 
FIG . 4D illustrates a reservoir assembly having a delivery embodiments . 
volume of 7 . 3 mL . Pump fluid chamber 460 comprises In some embodiments , a delivery fluid chamber may be 
curvature 471a , fluidly connected to hairpin 474a , fluidly configured to be replaceable and / or disposable . For example , 
connected to curvature 471b , fluidly connected to hairpin a delivery fluid chamber may be configured as a cartridge 
474b , fluidly connected to a curvature 471c , fluidly con - 60 that connects to a pump and / or a reservoir , a connection that 
nected to hairpin 474c , fluidly connected to curvature 471d , may be direct or through a connector . A connector may be 
fluidly connected to hairpin 474d , fluidly connected to fixed to a pump , a reservoir , a delivery fluid chamber , or 
curvature 471e , fluidly connected to hairpin 474e , fluidly combinations thereof . 
connected to curvature 471f , fluidly connected to an air vent . FIG . 5C is a sectional view of a reservoir system accord 
In some embodiments , components of a pump system 65 ing to a specific example embodiment of the disclosure 
may be manufactured at a low cost . FIG . 5A illustrates an along section lines 5C - 5C shown in FIG . 5B . FIG . 5C 
exploded view of a pump according to a specific example illustrates a sectional view of the top and bottom layer inlets 
23 
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and outlets of the reservoir system according to a specific opening on the right bottom layer of the delivery fluid 
example embodiment of the disclosure . The left side of FIG . chamber , which comprises a cone or funnel 582 . 
5C depicts the tubular hosing of curvatures 573a , 573b , Pump Systems 
593a , 593b . Curvatures 573a and 573b are stacked directly Pumps may be configured to deliver medications continu 
over curvatures 593a and 593b . The right side of FIG . 5C 5 ously and / or intermittently according to some embodiments . 
depicts the tubular hosing of curvature 571a , 571b , 591a , For example , insulin pumps used by patients with diabetes , 
591b . Curvatures 571a and 571b are stacked directly over particularly Type 1 diabetes , may be programmed to deliver 
curvatures 591a and 591b . insulin continuously at a basal delivery rate , in accordance 
FIG . 5D is a sectional view of a reservoir system accord with a programmed or programmable delivery profile ( s ) , 
ing to a specific example embodiment of the disclosure 10 and also may be programmed to deliver insulin boluses ( e . g . , 
along section lines 5D - 5D shown in FIG . 5B . The left side specific doses of a drug delivered in a predetermined time 
of FIG . 5D depicts the left side of reservoir 550 , including period , for example , less than 1 hour , less than 30 minutes , 
delivery fluid outlet 599 of delivery fluid chamber 580 . The less than 10 min , and / or less than 5 min . ) , usually in 
left side of FIG . 5D depicts the tubular hosing of curvature conjunction or anticipation of carbohydrate intake ( e . g . , 
573a , 573b , 593a , 593b . Curvatures 573a and 573b are 15 meals ) or anticipated or onset of glycemic excursions . While 
stacked directly over curvatures 593a and 593b , respec - insulin increases the consumption of glucose by cells of the 
tively . Curvature 593a also connects to delivery fluid outlet body , glucagon induces conversion of stored glycogen to 
599 . The right side of FIG . 5D depicts the right side of glucose , increasing the concentration of glucose in body 
reservoir 550 , including air inlet 578 of the water chamber fluids . In the management of diabetes , a pump system may 
560 . The right side of FIG . 5D depicts the tubular hosing of 20 deliver glucagon and / or insulin . A two - pump system com 
curvatures 571a , 571b , 591a , 591b . Curvatures 571a and prising both an insulin pump and a glucagon pump may be 
571b are stacked directly over curvatures 591a and 591b . of particular value in diabetes management because it may 
FIG . 5E is a sectional view of a reservoir system accord allow both up and down adjustment of the glycemia and may 
ing to a specific example embodiment of the disclosure decrease the duration and / or likelihood of the unwanted 
along section lines 5E - 5E shown in FIG . 5B . This view 25 hyperglycemic and / or hypoglycemic periods . 
illustrates gap 555 , into which a pump may be inserted , and Pumps may be configured to deliver drugs ( e . g . , continu 
couplings 561 and 581 to which a pump may be fluidly ously and / or intermittently ) that are useful in managing 
coupled . It also illustrates delivery fluid outlet 599 . Parkinson ' s disease , for example , drugs typically having 
FIG . 5F illustrates an elevation view of the reservoir in - vivo half - lives of less than 4 hours ( e . g . , between about 
system shown in FIG . 5B according to a specific example 30 30 min and about 3 hours , between 1 hour and 2 hours ) . 
embodiment of the disclosure . FIG . 5F depicts the delivery Examples of drugs that may be useful in managing Parkin 
fluid outlet . son ' s disease include water soluble L - DOPA prodrugs , apo 
FIG . 5G is a sectional view of a reservoir system accord - morphine , lisuride , L - DOPA decarboxylase inhibitors and / or 
ing to a specific example embodiment of the disclosure catechol - O - methyl transferase inhibitors . 
along section lines 5G - 5G shown in FIG . 5F . FIG . 56 35 Fluid pumps ( e . g . , drug pumps ) may also be used to 
depicts a water chamber of the reservoir system according to deliver a solution of a drug ( e . g . , a biological and / or chemi 
a specific example embodiment of the disclosure . An open - cal ) having a short half - life in the body of a subject . 
ing of the water chamber is fluidly connected to first Examples of short - lived chemicals may include , in some 
curvature 571a , fluidly connected to straight section 572a , embodiments , short - lived antibiotics , like gentamicin , 
fluidly connected to second curvature 573a , fluidly con - 40 tobramycin and cefotaxime . Gentamicin is not well 
nected to hairpin 574 , fluidly connected to first curvature absorbed when orally administered , but is well absorbed 
573b , fluidly connected to straight section 572b , fluidly when subcutaneously and intramuscularly delivered . Its 
connected to second curvature 571b . FIG . 5G also depicts elimination half - life in patients with normal renal function 
water chamber air inlet 578 . may be as short as 2 hours , making its continuous and / or 
FIG . 5H illustrates a sectional view of a reservoir system 45 frequent delivery potentially advantageous . Gentamicin may 
according to a specific example embodiment of the disclo - be used , for example , in the treatment of severe infections by 
sure along section lines 5H - 5H shown in FIG . 5F . FIG . 5H Gram - negative bacteria like Streptococcus aureus and is 
depicts delivery fluid chamber 580 of a reservoir system , in used , for example , in treating septicemia , neonatal sepsis , 
which the opening of delivery fluid chamber 580 is fluidly neonatal meningitis , biliary tract infection , pyelonephritis , 
connected to first curvature 593b , fluidly connected to 50 prostatitis and endocarditis . Tobramycin may have a serum 
straight section 592b , fluidly connected to a second curva - half - life in normal individuals of about 2 hours . It may be 
ture , fluidly connected to hairpin 594 , fluidly connected to effective , for example , against pneumonia , particularly when 
first curvature 591a , fluidly connected to straight section caused by Pseudomonas aeruginosa . Cefotaxime has an 
592a , fluidly connected to second curvature 593a . elimination half - life of merely 1 . 1 hours , making its con 
In some embodiments , a top chamber may comprise 55 tinuous and / or frequent pumping potentially of particular 
pumped water . In some embodiments , a bottom chamber interest . It may be effective in treatment of infections of the 
may comprise a delivery fluid solution . In some embodi - respiratory tract , skin , bones , joints , urogenital system , 
ments , a diameter channel for a chamber may be less than 3 meningitis , and septicemia caused by many Gram - negative 
mm . In some embodiments , a channel diameter ( e . g . , ID bacteria . It is , for example , active against penicillin - resistant 
and / or OD ) may vary along its length . 60 strains of Streptococcus pneumoniae . 
FIG . 51 illustrates a generally isometric view of the In some embodiments , active pharmaceutical ingredients 
reservoir system shown in FIGS . 5B - 5H . FIG . 51 depicts the that may be pumped include , heparin ( e . g . , used to control 
water chamber proximal fill inlet 563 . FIG . 51 depicts the blood coagulation ) , interferon ( e . g . , used in the therapy of 
opening on the left top layer of the water chamber which C - type hepatitis ) or ketamine ( e . g . , used in pain manage 
comprises a cone or funnel 562 . 65 ment , for example , in conjunction with opioid drugs like 
FIG . 5J illustrates a generally isometric view of the morphine and its derivatives ) . Pumping in accordance with 
reservoir system shown in FIGS . 5B - 51 . FIG . 5 ) depicts the some embodiments of the disclosure may also be desirable 
25 
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( e . g . , advantageous ) when therapy is better achieved by cation . In some embodiments , a system may comprise a 
maintaining a substantially constant concentration of a drug transmitter and / or receiver . In some embodiments , a system 
or substance in a body fluid , such as serum , and / or when may comprise an alarm . In some embodiments , a system 
therapy requires selective drug delivery to targeted organ or may comprise a reusable , removable ( pop - out ” ) electronic 
tissue ( e . g . , as is the case in chemotherapy of most cancers ) . 5 package in its center . In some embodiments , an electronic 
Systems comprising the pumps can also be configured to package may comprise a constant current supply and an deliver multiple drugs from multiple reservoirs , for example LCD or an electrophoretic ( e . g . , E - sink ) or another display . 
two drugs from two separate reservoirs . Delivery from In some embodiments , a removable electronic package may separate reservoirs can be simultaneous or non - simultaneous comprise an electrically coupled processor , memory , user ( e . g . , staggered , sequential , overlapping , intermittent ) . For 10 interface , ( i . e . , one or more control buttons ) and a power example a first fluid ( e . g . , comprising a drug ) may be source . In some embodiments , an electronic system may delivered from a first reservoir for a first period at a first flow 
rate followed by delivery of a second fluid ( e . g . , comprising comprise a wireless controller . In some embodiments , an 
a drug ) from a second reservoir for a second period at a electronic system may comprise RF communication . In some embodiments , an electronic system may comprise second flow rate . 
In some embodiments , a device delivering fluids ( e . g . , blue - tooth technology . A controller may be contained within 
drugs ) may include a pump ( e . g . , drug pump , insulin pump ) , the unit that is physically connected to a pump ( e . g . , a 
a reservoir , a controller , one or more sensors , or combina catheter ) or it may be spaced away and / or operate remotely 
tions thereof . A fluid pump system ( e . g . , a medication pump in some embodiments . A controller may be contained , for 
system ) may comprise , in some embodiments , flow - causing 20 example in a wrist watch and / or a mobile communication 
components , metering components ( e . g . , accurate drug dos device ( e . g . , a cell phone ) . 
ing components ) , and / or an implanted needle or cannula , the FIG . 6A illustrates an elevation view of pump system 600 
needle or cannula connected through a plastic tubing to a comprising pump 610 , pump fluid chamber 660 , delivery 
flow - causing pump . A fluid delivery system may pump fluid chamber 680 , air - inlet 678 , delivery fluid outlet 699 , 
and / or deliver a defined volume of a fluid ( e . g . , drug 25 and controller 601 , according to a specific example embodi 
containing solution and / or a solution containing multiple ment of the disclosure . Compared to FIG . 6B , pump fluid 
drugs ) , stored in a reservoir . A needle may be optionally chamber 660 and delivery fluid chamber have been straight 
short , its length between about 0 . 3 cm and about 1 cm , and ened , for illustration purposes , to be collinear with pump 
its gauge may be , for example , between about 22 and about 610 . FIG . 6A depicts a pump fluid chamber 660 filled with 
32 and / or between about 26 and about 29 . A needle ( e . g . , a 30 a separator 657a in fluid communication with a first aliquot 
narrow gauge needle ) , may be optionally inserted in order to of pump fluid 656a and delivery fluid chamber 680 is filled 
reduce the extent to which its presence is felt by the wearer with a second aliquot of pump fluid 656b , in fluid commu 
of the skin - attached drug pumping system in the skin of the nication with separator 657b and fluidly connected to deliv 
belly , the tip of the needle residing in the fatty tissue may ery fluid 658 . A separator may be a liquid or a solid . 
often be found below the skin of the belly . A needle may be 35 Examples of a liquid separator may include , for example , 
inserted in an intravenous port in some embodiments . A silicone oil or a glycerol mono or di - ester of a fatty acid . 
delivery fluid , according to some embodiments , may com Solid separators may be plastic , ceramic or metallic in some 
prise a pharmaceutical agent used to treat a condition embodiments . Once pumping begins pump fluid 656a from 
requiring treatment in humans or in animals , a nutrient , a pump fluid chamber 660 passes through pump 610 and 
nutrient supplement , and / or a vaccine . Insulin may be an 40 begins to accumulate in delivery fluid chamber 680 and push 
example of a drug in some embodiments . A delivery fluid separator 657b , which pushes delivery fluid 658 to outlet 
comprising a drug may further include a solution in which 699 . 
the drug may be dissolved and / or dispersed . FIG . 6B illustrates miniature skin - adhered fluid - delivery 
A pump system , in some embodiments , may comprise a system 600 shown in FIG . 6A in accordance with certain 
reference electrode . For example , a reference electrode may45 exemplary embodiments . FIG . 6B depicts a delivery fluid 
be included to monitor potentials relative to an anode and / or chamber 680 , pump 610 , controller 601 , and pump fluid 
a cathode . A reference electrode may be desired , in some chamber 660 . Delivery fluid 658 ( e . g . , a drug - containing 
embodiments , to monitor the presence of reactant . For solution ) is densely speckled and pump fluid 656 is lightly 
example , the potential between an anode and a reference speckled . The structure at the top - center of FIG . 6B ( i . e . , 
electrode or between a cathode and a reference electrode 50 separating pump fluid compartment 660 from delivery fluid 
may rise when reactant at the anode or cathode , respectively , compartment 680 ) depicts electro - osmotic pump 610 dis 
has been depleted . A controller may be configured to termi closed herein . Its outer diameter is 8 mm . The large trans 
nate flow upon detecting a potential relative to a reference parent plastic disc mimics the skin . It is penetrated by a 5 
electrode within a range ( e . g . , a predetermined range ) and / or mm long 29 gauge syringe needle 606 as shown in FIG . 6C . 
above a threshold ( e . g . , a preset threshold ) . 55 System 600 is adhered to the transparent plate that mimics 
In some embodiments , a volume and / or delivery rate of a the skin with two - sided adhesive tape 605 . As depicted , 
drug or drug solution , described herein , may be controlled system 600 has reusable , removable ( pop - out ” ) electronic 
by a pump system . In some embodiments , a pump system package 601 in its center ( FIG . 6D - 5G ) . As depicted in the 
may comprise a pump connected to a computer ( e . g . , a embodiment of FIG . 6B , pump fluid chamber 660 of system 
personal computer , microcontroller , or the like ) via an 60 600 may contain pump fluid 656a and delivery fluid cham 
external interface . In some embodiments , a system may be ber 680 may contain delivery fluid 658 ( e . g . , insulin mimic ) , 
controlled , for example by an external interface comprising which does not pass through pump 610 . According to this 
an interface cable for an external interface option to an embodiment , a pump ' s active area may be about 0 . 3 cm . 
external controller comprising a 3V lithium battery , and one Delivery fluid chamber 680 may also include separator 657b 
or more control buttons . In some embodiments , control 65 separating pump fluid 656b and delivery fluid 658 . During 
buttons may allow , for example , programming of a current operation , separator 657b moves as pump fluid 656b , shown 
to be applied to a pump , and time duration of such appli - colorless , displaces delivery fluid 658 . 
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The large transparent plastic disc to which system 600 is to the diameter of membrane 720 . FIG . 7A depicts a proxi 
attached , mimics skin for illustration purposes and may be mal end 767 , a medial portion 770 and a distal end 775 of 
replaced in actual use by human or animal skin . This plastic pump fluid chamber 760 . Pump fluid chamber 760 com 
disc is penetrated by syringe needle 606 as shown in FIG . prises 3 external fluid connections , namely air inlet 778 for 
6C . FIG . 6C illustrates an isometric view of a pump system 5 admitting air into pump fluid chamber 760 during pump 
according to a specific example embodiment of the disclo - operation ; separator distal fill inlet 776 and septum 777 for 
sure . When delivery fluid 658 is pushed out of the drug installing a volume ( e . g . , a small volume ) of a separator fluid 
outlet 699 it reaches needle 606 , which is inserted into a in pump fluid chamber 760 ; and pump fluid inlet 763 and 
subject . FIG . 6C depicts an embodiment comprising an septum 764 for loading a volume ( e . g . , a small volume ) of 
adhesive patch 605 for attachment of the system to a subject . 10 pump fluid in pump fluid chamber 760 in contact with pump 
In some embodiments , the needle may be an about 5 mm 710 . 
long , about 29 gauge syringe needle 606 . According to the Pump 710 is fluidly connected to delivery fluid chamber 
depicted embodiment , the system is adhered to the trans - assembly 780 via pump coupling 781 through a delivery 
parent plate that mimics the skin with two - sided adhesive fluid chamber opening 785 of the delivery fluid chamber 
tape 605 . In other embodiments , a system may be attached 15 780 . Coupling 781 includes cone 782 , the diameter of which 
to a subject using an elastic band . Optionally , a needle may narrows ( from left to right ) from the diameter of membrane 
be longer than about 5 mm ( e . g . , longer than about 7 mm ) , 720 to the insider diameter of delivery fluid chamber 780 . 
and / or shorter than 9 mm . In some embodiments , a needle Delivery fluid chamber 780 comprises a proximal end 787 , 
may be inserted in a subject ( e . g . , the skin ) . The angle of medial portion 790 and distal end 795 . Medial portions 770 
insertion ( e . g . , relative to the plane of the skin ) may be from 20 and 790 may include various curvatures , straight sections , 
15° to about 45° versus the plane of the skin . The angle of and / or hairpins according to some embodiments ( e . g . , FIGS . 
insertion ( e . g . , relative to a line normal to the skin ) may be 4B - 4D ) . Proximal end 767 and 787 and distal ends 775 and 
from about 75° to about 45° . A needle may have a diameter 795 may independently include various curvatures , straight 
from about 31 gauge to about 23 gauge . sections , and / or hairpins according to some embodiments . 
FIG . 6D illustrates a plan view of a constant current ) 25 Delivery fluid chamber 780 also comprises 4 external fluid 
voltage controller and timer according to a specific example connections , namely pump fluid inlet 783 and septum 784 
embodiment of the disclosure . FIG . 6D depicts a controller for loading a volume ( e . g . , a small volume ) of pump fluid in 
601 , comprising a user interface 601d , LCD display 601e , an delivery fluid chamber 780 in contact with pump 710 ; 
electrically coupled processor , memory , and power source . Separator fluid inlet 796 and septum 797 for installing a 
As depicted controller 601 of FIG . 6D further comprises two 30 volume ( e . g . , a small volume ) of a separator fluid in delivery 
control buttons 601d for programming of the current to be fluid chamber 780 ; delivery fluid inlet 798 and septum 798a 
applied to pump 610 , and the time ( e . g . , duration and / or for installing a volume of a delivery fluid in delivery fluid 
interval ) of such application . These two settings ( i . e . , the chamber 780 ( e . g . , filling chamber 780 ) ; and delivery fluid 
combination of current and time ) may define the delivered outlet 799 . 
volume and / or the delivery rate ( i . e . , the flow rate ) . Accord - 35 FIG . 7B illustrates a sectional view of pump system 750 
ing to the depicted embodiment , the dimensions of the according to a specific example embodiment of the disclo 
system are 36 mmx30 mmx8 mm . sure . FIG . 7B depicts the same components depicted in FIG . 
FIG . 6E illustrates a plan view of a constant current 7A . FIG . 7C illustrates a sectional view of pump system 750 
voltage controller and timer according to a specific example according to a specific example embodiment of the disclo 
embodiment of the disclosure . FIG . 6E depicts an electri - 40 sure . FIG . 7C depicts the same components depicted in FIG . 
cally coupled processor 601a , memory 601b , and power 7A . In some embodiments , the shape and / or relative location 
source 601c . of coupling 761 , cone 762 , opening 765 , coupling 781 , cone 
FIG . 6F illustrates an exploded view of the controller 782 , and / or opening 785 may impact the flow of fluids 
shown in FIG . 6E according to a specific example embodi through pump 710 . It may be desired and / or required to 
ment of the disclosure . FIG . 6F depicts a processor 601a , 45 arrange coupling 761 , cone 762 , opening 765 , coupling 781 , 
memory 601b , and power source 601c electrically coupled , cone 782 , and / or opening 785 in an oblique configuration 
and a LCD display 601e and user interface 601d . ( e . g . , FIG . 7A ) , a linear , centered configuration ( e . g . , FIG . 
FIGS . 7A - 7C illustrate embodiments of system 700 com - 7B ) , a linear , off - center configuration ( e . g . , FIG . 7C ) . 
prising a reservoir assembly in which pump fluid chamber In some embodiments , an outer diameter of an electro 
760 and delivery fluid chamber 780 have been rendered , for 50 osmotic pump may be about 1 cm or less , for example , about 
illustration purposes , as coplanar with each other and with 0 . 8 cm or less . Thus the cross - sectional area of a pump may 
pump 710 similar to the collinear arrangement shown in be less than 1 cm² , less than 0 . 8 cm² , and / or about 0 . 5 cm ? 
FIG . 6A . Pump fluid chamber 760 and delivery fluid cham - or less . In some embodiments , a pump may be powered by 
ber 780 may be configured as illustrated or may be config - a small cylindrical , optionally coin - type , battery with an OD 
ured such that pump fluid chamber 760 substantially over - 55 of , for example , less than 13 mm , less than 8 mm , and / or less 
lays delivery fluid chamber 780 and the two together define , than 6 mm . A battery may be a nominally about 1 . 4 V open 
at least partially , an oval and / or a circle ( e . g . , as shown in circuit voltage ( OCV ) alkaline Zn - air battery . Alternatively , 
FIGS . 4B - 4D . a pump may be powered by a nominally about 1 . 4 V OCV 
FIG . 7A illustrates a sectional view of pump system 750 alkaline Zn - manganese dioxide battery , or by a nominally 
according to a specific example embodiment of the disclo - 60 about 1 . 6 V OCV Zn - silver oxide battery , or by a nominally 
sure . Pump 710 comprises membrane 720 , anode 730 , and about 2 . 8 V or higher OCV lithium anode battery , such as the 
cathode 740 . Pump fluid chamber assembly 760 depicted in 3 . 2 V OCV Li - manganese dioxide battery . A pump in some 
FIG . 7A , is located to the left of pump 710 and pump fluid embodiments may provide a flow rates of about 1 - 40 
chamber opening 765 is coupled with pump coupling 761 , ?L / min . In some embodiments , with an about 3 V OCV 
which is fluidly coupled to pump 710 . Coupling 761 65 lithium anode battery , a flow rate of between about at least 
includes a cone , the diameter of which expands ( from left to 20 uL / min and about 40 uL / min may be sustained . In some 
right ) from the insider diameter of pump fluid chamber 760 embodiments , a flow rate between about 3 uL / min and about 
29 
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20 uL / min may be sustained with a 1 . 4 V zinc - manganese FIGS . 9A - 9E illustrate steps for loading pump system 
dioxide alkaline battery . Some examples of small batteries 900 , which comprises pump 910 , water chamber 960 , and 
that can be used are shown in Table 1 . All have sufficient drug solution chamber 980 and parallel FIGS . 8A - 8E . Wires 
capacity for electro - osmotically pumping at least about 16 936 and 946 are in electrical communication with anode 930 
mL of the solutions disclosed here , containing enough 5 and cathode 940 , respectively , of pump 910 . FIG . 9A 
insulin for at least about a month or about 100 meals . illustrates an isometric view of pump system 900 in which 
According to some embodiments , a pump system may water chamber 960 is loaded with water 956a through water 
comprise one or more sensors . For example , a pump may inlet 963 according to a specific example embodiment of the 
contain a sensor for detection of the volume of delivery fluid disclosure . FIG . 9B illustrates an isometric view of pump 
administered to a subject . Delivery fluid volume may be 10 system 900 in which water chamber 960 is loaded with oil 
assessed by , for example , monitoring the position of a 957a ( black ) through oil inlet 976 according to a specific 
separator . In some embodiments , a separator may be colored example embodiment of the disclosure . FIG . 9C illustrates 
( e . g . , using a visible ink or dye , a luminescent agent , a an isometric view of pump system 900 ( flipped over relative 
phosphorescent agent , or the like ) . A sensor ( e . g . , a photo to FIG . 9B ) in which drug solution chamber 980 is loaded 
sensitive film ) may be positioned sufficiently close to the 15 with drug solution 956b through drug solution inlet 983 
marked separator to permit the film to detect separator according to a specific example embodiment of the disclo 
movement ( e . g . , adhered to a pump system housing ) . A sure . FIG . 9D illustrates an isometric view of pump system 
sensor may be arranged in communication with a controller , 900 in which drug solution chamber 980 is loaded with oil 
according to some embodiments . A controller in communi - 957b ( black ) through oil inlet 996 according to a specific 
cation with a sensor may adjust the potential difference 20 example embodiment of the disclosure . FIG . 9E illustrates 
and / or a current across a membrane ( e . g . , to adjust delivery an isometric view of pump system 900 in which drug 
to a desired flow rate , dose , volume , duration , or the like ) . solution chamber 980 is loaded with a drug solution 958 
TABLE 1 
Exemplary Useful Batteries 
Battery Stock number Thickness OD Weight Voltage Capacity 
Zinc Air LIOZA 
Silver Oxide Energ . 364 / 363 
Silver Oxide Energ . 377 / 376 
Lithium Energ . CR1025 
Lithium Energ . CR1220 
3 . 6 mm 
2 . 15 mm 
2 . 60 mm 
2 . 50 mm 
2 . 00 mm 
5 . 8 mm 
6 . 80 mm 
6 . 80 mm 
10 . 00 mm 
12 . 50 mm 
0 . 31 g 
0 . 37 g 
0 . 42 g 
0 . 70 g 
0 . 78 g 
1 . 4 V 
1 . 55 V 
1 . 55 V 
3 . 0 V 




60 mW : h 
80 mW . h 
Loading Methods for Pump Systems 35 ( speckled ) through drug solution inlet 998 according to a 
FIGS . 8A - 8E illustrate steps for loading reservoir assem - specific example embodiment of the disclosure . In some 
bly 850 ( shown only FIGS . 8D - 8E ) in which pump fluid embodiments , drug outlet 999 may be fluidly connected to 
chamber 860 and delivery fluid chamber 880 have been a catheter or needle inserted into a subject ( e . g . , when used ) . 
rendered , for illustration purposes , as coplanar with each It may be desirable and / or required , according to some 
other and with pump 810 similar to the collinear arrange - 40 embodiments , to complete one or more of the loading steps 
ment shown in FIG . 6A and FIGS . 7A - 7C . Pump fluid shown in FIGS . 9A , 9B , 9C , 9D , and / or 9E in a one or more 
chamber 860 and delivery fluid chamber 880 may be con facilities ( e . g . , manufacturing facilities ) . In some embodi 
figured as illustrated or may be configured such that pump ments , an end user may optionally complete one or more of 
fluid chamber 860 substantially overlays delivery fluid the loading steps shown in FIGS . 9A , 9B , 9C , 9D , and / or 9E . 
chamber 880 and the two together define , at least partially , 43 For example , an end user may complete the loading step 
an oval and / or a circle ( e . g . , as shown in FIGS . 4B - 4D . shown in FIG . 9E ( e . g . , immediately prior to use ) . 
FIG . 8A illustrates a sectional view of pump system 800 In addition , a reservoir may be configured and arranged to 
in which pump fluid chamber 860 is loaded with pump fluid be prefilled with a fluid and / or interchangeably engaged with 
856a through pump fluid inlet ( arrow ) according to a spe - so a pump . A prefilled reservoir may be loaded , in some 
cific example embodiment of the disclosure . FIG . 8B illus embodiments , as otherwise disclosed herein . According to 
trates a sectional view of pump system 800 in which pump some embodiments , a prefilled reservoir may be loaded 
fluid chamber 860 is loaded with separator fluid 857a through a fluid chamber opening proximal to where it 
through separator fluid inlet 876 ( arrow ) according to a engages a pump ( e . g . , a reservoir gap ) . A removable plug 
specific example embodiment of the disclosure . FIG . 8C 55 may be positioned over a fluid chamber opening to reduce or 
illustrates a sectional view of pump system 800 in which prevent fluid loss after loading and prior to pump engage 
delivery fluid chamber 880 is loaded with pump fluid 856 ment . For example , a single , removable plug having oppos 
through pump fluid inlet 883 ( arrow ) according to a specific ing covers may be positioned in a reservoir gap such that the 
example embodiment of the disclosure . FIG . 8D illustrates respective chamber openings are occluded by the covers . In 
a sectional view of pump system 800 in which delivery fluid 60 some embodiments , a plug may be positioned to cover 
chamber 880 is loaded with separator fluid 857b through opposing reservoir chambers and still allow a pump to be 
separator fluid inlet 896 ( arrow ) according to a specific engaged with a reservoir gap . For example , a reservoir gap 
example embodiment of the disclosure . FIG . 8E illustrates a may receive a pump from one face and permit removal of a 
sectional view of pump system 800 in which delivery fluid plug ( e . g . , a strip of tape ) from the opposite face once the 
chamber 880 is loaded with delivery fluid 858 through 65 pump is engaged . A plug , pump , and / or reservoir may be 
delivery fluid inlet 898 ( arrow ) according to a specific configured such that engaging the pump concurrently dis 
example embodiment of the disclosure . places the plug in some embodiments . Plug removal and / or 
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pump engagement may be performed without introducing anesthetic ( e . g . , lidocaine , tetracaine , and bupivicaine ) ; a 
fluid leaks ( e . g . , gas into a reservoir or liquid release from dopamine agonist ( e . g . , apomorphine , rotigotine , and rop 
a reservoir ) . inerole ) ; drugs used for the treatment and / or prevention of 
In some embodiments , a disposable cartridge ( reservoir ) allergies ( e . g . , an antihistamine , an antileukotriene , an anti 
may have one or more septums ( e . g . , elastomeric septums ) . 5 cholinergic , and an immunotherapeutic agent ) ; an antispas 
Fluid communication with the contents of a disposable tic ( e . g . , tizanidine and baclofin ) ; a vitamin ( e . g . , niacin ) ; cartridge ( e . g . , a chamber ) may be established by piercing a Selegiline ; rasagiline ; and any combination thereof . A bio 
septum , for example , with a hollow needle ( e . g . , a steel logical material may be or may comprise a protein , a needle ) . A prefilled reservoir may comprise , in some peptide , a nucleic acid ( e . g . , an oligonucleotide ) , a lipid , embodiments , two chambers , each about completely filled , 10 and / or a carbohydrate . one with a pump fluid and the other with a delivery fluid , and In some embodiments , a pump system may administer a each having an end at least partially defined by a septum combination of two or more APIs . For example , a pump ( e . g . , a rubber septum ) . system may be configured to include a single delivery fluid Pump System Operation 
According to some embodiments , a fluid pump system 15C chamber filled with the combination . A pump system may be 
( e . g . , a medication pump system ) may deliver a fluid ( e . g . , configured , for example , to include two or more delivery 
an insulin solution and / or suspension ) stored in a reservoir fluid chambers that feed into a common catheter / needle or 
connected by a tubing to a cannula implanted or a hollow separate catheters / needles . In some embodiments , a pump 
needle in a body tissue . A fluid may be delivered , for system may be configured to deliver two or more APIs at a 
example , subcutaneously , optionally into fatty tissue . 20 fixed ratio and / or a variable ratio . A pump system may be 
According to some embodiments , a cannula , ( e . g . , a plastic configured to delivery each API subject to independent 
cannula ) and / or a high gauge ( e . g . , fine ) hollow needle ( e . g . , delivery modulation in some embodiments . For example , 
a stainless steel needle ) , for example a 27 , 28 , 29 , 30 or 31 two or more drugs may be administered simultaneously 
gauge needle , may be implanted in the body of a subject for and / or sequentially ( e . g . , overlapping ) . 
fluid delivery . A cannula and / or needle may be connected 25 A fluid delivery system may operate , in some embodi 
through a plastic tubing to the source of a pumped fluid ( e . g . , ments , by indirect pumping . For example , a pump fluid ( e . g . , 
drug ) . For the intravenous delivery a hollow needle ( e . g . , a solution containing little or no drug to be delivered , such 
connected to a fluid pump through a tubing ) may be inserted as deionized water ) may pass through a pump , whereas a 
in a septum of an intravenous port , connected by a catheter delivery fluid does not , but instead is pushed by a pump 
to a vein ( e . g . , a Portacath ) . Ports may be used , for example , 30 fluid . In some embodiments , a separator may be a displace 
to treat hematology and oncology patients . able and / or deformable water insoluble solid , a water 
In some embodiments , a dissolved or solution - dispersed immiscible liquid , and / or a water - immiscible gas ( e . g . , air ) 
chemical ( e . g . , an active pharmaceutical ingredient ) may be preventing the mixing of a pump fluid and a delivery fluid . 
delivered to a tissue of a subject ( e . g . , subcutaneously , In some embodiments , control ( e . g . , strict control ) of a 
intravenously , intraperitoneally , and / or intrathecally ) . In 35 dosage and dose - rate ( i . e . , delivered volume and flow rate ) 
some embodiments , a medication delivery system may be of may be desired and / or required . In some embodiments , a 
a type that delivers insulin stored in a remote reservoir flow rate may be controlled by a constant voltage supply . In 
connected by the tubing to a cannula , or in a unit that is skin some embodiments , a flow rate may be controlled by a 
mounted or attached with its cannula connected by a short constant pressure . In some embodiments , flow rate may be 
tubing . In some embodiments , the volume of a fluid delivery 40 controlled by an applied current . In some embodiments , flow 
system ( e . g . , a medication infusion system ) may be smaller rate may be controlled by an applied voltage . In some 
than about 100 cm " , for example , smaller than about 20 cm " , embodiments , a flow rate may be continuous . In some 
and , for example , smaller than about 10 cm " , for example , embodiments , electrode mass and / or consumption of an 
smaller than about 5 cm° . In some embodiments , a reservoir anode and / or cathode may allow for 7 hours of continuous 
may contain a sufficient volume of drug solution or disper - 45 Operation at a flow rate of 15 uL / min . In some embodiments , 
sion for about 1 - 10 day therapy , in some cases about 2 - 3 day an average flow rate may be controlled by pulsing ( e . g . , 
therapy , and often about 1 day therapy . periodic voltage and / or current pulsing ) . For example , flow 
A delivery fluid may comprise , according to some rate may be controlled by pulsing over a period of about 4 
embodiments , a biological and / or chemical material . For days , about 3 days , about 2 days , about 1 day , about hourly , 
example , a delivery fluid may comprise an active pharma - 50 every about 50 minutes , every about 40 minutes , every about 
ceutical ingredient ( API ) ( e . g . , a drug ) . A delivery fluid may 30 minutes , every about 20 minutes , every about 10 minutes , 
be or may comprise an API as or in a solution , a suspension , every about 5 minutes , every about 2 minutes , every about 
and / or an emulsion in some embodiments . A delivery fluid 1 minute , every about 20 seconds . In some embodiments , an 
may comprise one or more excipients ( e . g . , pharmaceuti - average flow rate of 0 . 13 ?L / min may be obtained by 
cally acceptable excipients ) . For example , a delivery fluid 55 applying 10 second pulses of 75 u? , every 15 minutes . 
may comprise any pharmaceutically acceptable vehicle for In some embodiments , application of a current ( or volt 
an API . A non - aqueous vehicle may comprise , in some age ) across electrodes of a pump may drive protons to the 
embodiments , vegetable oils , polyethylene glycols , esters cathode , where they may be consumed by a cathodic reac 
( e . g . , ethyl oleate ) and the like . A vehicle may comprise , in tion . Without being limited to any particular mechanism of 
some embodiments , one or more antibacterial preservatives , 60 action , protons may propagate rapidly at the polyanionic 
antioxidants , tonicity agents , buffers , stabilizers , and / or surface of a ceramic membrane dragging the proximal water 
other components . sheet , which transfers momentum to the water - bulk causing 
An API may be and / or may comprise , according to some its flow . In some embodiments , ( e . g . , where electro - osmotic 
embodiments , an opioid narcotic ( e . g . , fentanyl , remifenta - flow is driven by a fast proton flux at the surface of a 
nyl , sufentanil , morphine , hydromorphone , oxycodiene and 65 sandwiched porous membrane and / or adsorption of an impu 
salts thereof ) ; a non - steroidal antinflamatory ( NSAID ) ( e . g . , rity on the membrane perturbs flux ) it may be desirable to 
diclofenac , naproxen , ibuprofen , and celecoxib ) ; a local use pure protic liquids like water as a pump fluid . 
TOI 
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In some embodiments , an electro - osmotic flow is driven illustrates a sectional view of pump system 1000 near 
by a fast proton flux at the surface of a sandwiched porous completion of operation according to a specific example 
membrane . In some embodiments , a delivery fluid is pushed embodiment of the disclosure . Flow may be slowed and / or 
by pumped water . In some embodiments , dilution of a stopped by reducing the potential difference and / or current 
delivery fluid solution by pumped water is avoided by a 5 applied to pump 1010 ( e . g . , to about zero ) . In FIG . 10C , flow 
separator ( i . e . , an oil drop and / or a gas bubble ) inserted is stopped with some delivery fluid still remaining in cham 
between a water and delivery fluid . In some embodiments , ber 1080 . 
to prevent a separator ( e . g . , oil drop ) from reaching the In some embodiments , an electro - osmotic pump may 
subcutaneous tissue , the volume of a pump fluid ( or pump comprise ( i ) one or more phosphorus - containing membranes fluid + pump chamber separator ) may be less ( e . g . , about 0 . 5 10 ( e . g . , a phosphosilicic acid on silica membrane ) and / or mL less , about 0 . 2 mL less , and / or about 0 . 1 mL less ) than boron - containing membranes ( e . g . , a borosilicic acid on that of delivery fluid ( or delivery fluid + delivery chamber 
separator ) . In some embodiments , delivery fluid ( e . g . , water ) silica membrane ) , ( ii ) a non - gassing ( e . g . , absence of gas 
in a delivery fluid chamber may become exhausted and bubbles visible to the naked eye ) , electrooxidizable and 
separator ( e . g . , oil ) may enter a pump , whereupon flow may 15 proton - generating porous anode constituent ( e . g . Ce® ) , and / 
be reduced and / or stopped . At that time , some delivery fluid or ( 111 ) a non - gassing , hydroxide anion generating or proton 
may remain in a delivery fluid chamber . It may be desirable , consuming cathode constituent ( e . g . Ce + + ) . When operated 
in some embodiments , for the volume of delivery fluid at low voltages , where no gas evolution causing electrolysis 
remaining to be as small as possible or as small as possible takes place , a pump may provide , in some embodiments , 
without compromising safety . 20 sufficient flow rates for the delivery of drugs ( e . g . , prandial 
In some embodiments , a separator may comprise a gas , a insulin ) and / or pumping cooling fluids , for example , to cool 
liquid and / or a solid . A gaseous separator , in some embodi - electronic and / or optical devices . According to some 
ments , may comprise an air bubble . In some embodiments , embodiments , a low voltage is a voltage of less than about 
an example of a useful liquid separator may be a silicone oil 3 V , for example less than 2 . 0 V , less than 1 . 5 V , less than 
or a glycerol mono or di - ester of a fatty acid . In some 25 1 . 0 V , less than 0 . 8 V , less than 0 . 6 V , about 0 . 5 V or less . 
embodiments , solid separators may be plastic , ceramic or According to some embodiments , a DC electro - osmotic 
metallic . In some embodiments , a separator moves along a pump may operate at a voltage of less than about 3 V ( e . g . , 
defined path when pushed by a pumped solution . In some less than 1 . 23 V which is the thermodynamic voltage for the embodiments , a solid separator may optionally also serve in electrolysis of water ) at about 25° C . A pump may comprise , stopping the flow when the delivery fluid is nearly or 30 for example , a porous , phosphorus containing membrane , completely exhausted , for example , by plugging an orifice for example a membrane made of phosphosilicic acid through which the delivery fluid enters the tubing connected coated , fused silica microspheres . Flow of deionized water to the body - inserted cannula . In some embodiments , for 
example , the downstream side of the plug can be conical , the may start at about 0 . 1 V and may increase about linearly with the applied current . The flow rate may be sufficient , for tip of the cone penetrating the cannula or its upstream 35 
extension when the delivery fluid is exhausted . In some example , for prandial insulin administration ( e . g . , bolus 
embodiments , combined volumes of a pumped solution and delivery ) . 
a delivery fluid may be minimized by making their volumes In some embodiments , electrodes may be re - charged ( i . e . , 
about similar , with the volume of a delivery fluid exceeding the anode made into the cathode and vice versa ) . For 
the volume of a pumped solution , so as to avoid delivery of 40 example , the electrodes may be rotated by reversing the 
only a pumped solution to the cannula . current , so that the Ce * + formed at the cathode in the 
FIGS . 10A - 10C illustrate pump system 1000 in operation operating pump from Ce4 + may be re - oxidized , while the 
in which pump fluid chamber 1060 and delivery fluid Cet + formed at the cathode in the operating pump from Ce3 + 
chamber 1080 have been rendered , for illustration purposes , may be re - reduced . 
as coplanar with each other and with pump 1010 similar to 45 To control their blood sugar levels , Type 1 diabetic people 
the collinear arrangement shown in FIGS . 6A , 7A - 7C , and need about 0 . 8 insulin units / kg / day . There are about 27 units 
8A - SE . Pump fluid chamber 1060 and delivery fluid cham - in 1 mg of insulin , and fast acting insulin solutions contain 
ber 1080 may be configured as illustrated or may be con - typically about 100 units / mL . The dosings and timings of 
figured such that pump fluid chamber 1060 substantially insulin vary from patient to patient . In the management of 
overlays delivery fluid chamber 1080 and the two together 50 Type 1 diabetes , in some patients , about 1 / 4 of the insulin , 
define , at least partially , an oval and / or a circle ( e . g . , as i . e . , about 0 . 2 insulin units / kg / day , are continuously admin 
shown in FIGS . 4B - 4D . istered , and about 0 . 2 insulin units / kg are administered with 
FIG . 10A illustrates a sectional view of pump system each of the three daily meals . In the case of a person 
1000 in which the chambers 1060 and 1080 are loaded and weighing 80 kg , about 16 units , i . e . , about 160 uL of fast 
ready for use according to a specific example embodiment of 55 acting insulin are delivered with a meal . For a 20 minute 
the disclosure . FIG . 10B illustrates a sectional view of a delivery the required pumping rate is about 8 uL / min . 
pump system shown in FIG . 10A during operation according Allergen Diagnostics 
to a specific example embodiment of the disclosure . Upon According to the website of the NIH - National Institute of 
application of a potential difference or current across pump Allergic Diseases , allergies are the sixth leading cause of 
1010 , pump fluid 1056a begins to flow through pump 1010 60 chronic disease in the United States . Their 2005 cost to the 
into delivery fluid chamber 1080 . Separator 1057a moves in healthcare system was about $ 18 billion . About half of all 
tandem with the distal edge of pump fluid 1056a and air is Americans test positive for at least 1 of the 10 most common 
drawn into chamber 1060 through inlet 1078 . As pump fluid allergens : Ragweed , bermuda grass , rye grass , white oak , 
1056a moves to and accumulates in chamber 1080 , the Russian thistle , alternaria mold , cat , house dust mite , Ger 
combined volume of 1056a and 1056b forces separator 65 man cockroach , peanut . Food allergy occurs in 6 - 8 % of 
1057b to move distally toward outlet 1099 , which in turn , children younger than 6 and in 2 % of adults . Common food 
expresses delivery fluid 1058 through outlet 1099 . FIG . 10C allergens include : Cow ' s milk ; eggs ; shellfish ; nuts . In 2005 , 
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30 million people living in the United States had asthma , system comprising the disclosed electro - osmotic pump . It 
resulting in > 480 , 000 hospitalizations and about 4 , 200 may be administered , for example , at a fixed flow rate ( e . g . , 
deaths . between about 0 . 1 uL min - 1 and about 10 uL min - 1 and / or 
According to some embodiments , a fluid delivery system between about 0 . 5 uL min - - and about 0 . 5 uL min ) until 
( e . g . , electro - osmotic pumps ) may also be used ( e . g . , advan - 5 the positive reaction indicative flare or wheal or combination 
tageously used ) in immunotherapy of allergies . According to of flare and wheal is observed , when the flow would be 
present practice , a series of increasingly concentrated sus stopped . The inverse elapsed timed between the start of the 
pensions or solutions of the allergen or allergens to which flow and the stopping of the flow would indicate the sensi 
the patient is sensitive are subcutaneously injected . The tivity to the tested allergen . Alternatively , the flow rate 
suspensions are administered over an extended period of 10 would be increased during the test , for example in 0 . 1 uL 
time , typically several years . The injections are believed to min - 1 increments , until the flare or wheal or combination of 
reduce the level of IgE antibodies in the blood and to cause flare and wheal is observed and the flow is stopped , for 
the body to make protective IgG antibodies . In present example , by removing the system . The inverse number of 
practice the patient needs to visit the office of the allergist , increments between the starting of the flow and its stopping 
wait to be injected by a nurse or other health professional , 15 would indicate the sensitivity to the tested allergen . Alter 
and then wait at least about 20 min to assure the absence of natively , small boluses may be intermittently administered . 
a severe allergic reaction to the administered dose . The Boluses may be of constant or increasing volume . In some 
dosing is usually sub - optimal , because the allergist wishes to embodiments , they would be larger than about 100 nL and 
be reasonably certain that there will not be a severe allergic smaller than about 10 uL . They may be delivered about 
reaction . Gradual delivery of the suspension or solution over 20 every 2 minutes or less , for example every minute or less , for 
a period longer than about 5 minutes ( e . g . , longer than about example every 30 s or less , for example every 10 s or less . 
10 min , longer than about 30 min , longer than about 1 hour , In a diagnostic system , the combined volumes of an 
longer than about 3 hours , and / or longer than about 6 hours ) allergen suspension or solution , a pumped aqueous solution 
would allow a subject to remove a skin - adhered system and a pump itself may total , according to some embodi 
containing an electro - osmotic or other drug pump if he or 25 ments , less than about 5 mL , less than about 2 mL , less than 
she observes excessive reddening or swelling indicative of about 1 mL , and / or less than about 0 . 5 mL . In some 
the start of an unwanted excessive allergic reaction . Such an embodiments , a system may have a generally circular and / or 
allergy immunotherapy system may have , other than the annular shape with a diameter of , for example , less than 
pump itself , two small compartments , of similar or different about 2 cm , less than about 1 cm , less than about 6 mm , less 
volumes . Each compartment may , independently , have a 30 than about 4 mm . According to some embodiments , an 
volume of , for example , less than about 2 mL , less than electro - osmotic pump system may be skin - attached , option 
about 1 mL , less than about 0 . 5 mL , and / or less than about ally off the site of the administration of the tested allergen , 
0 . 2 mL . One compartment may contain a pumped solution , so as not to block the view of the expected wheal and flare . 
( e . g . , de - ionized water or water containing less than about system may be worn , in some embodiments , for a period 
10 - - moles per liter of a solute ) and / or a second compart - 35 longer than about 2 min , longer than about 5 min , longer 
ment may contain a suspension or solution of one or more than about 10 min , longer than about 30 min , and / or until a 
allergens . The two compartments may be separated by a positive reaction indicative flare is observed . Flow may then 
moving separator , which may be moved by a pumped be stopped and the system would be optionally removed 
solution ( e . g . , de - ionized water ) , and push an allergen - from the skin . Optionally , the flow would be automatically 
containing suspension . A system may also comprise means 40 stopped and the elapsed time or number of boluses measured 
to attach it to the skin , such as a non - allergic two sided when the flare or the wheal develop . For such automatic 
adhesive tape used by wearers of wigs and hairpieces , and monitoring or control of flow , a system may also comprise 
a short hollow needle , which may be , for example , longer a detector or multiple detectors , for example of reflected 
than about 0 . 1 cm and shorter than about 0 . 6 cm and / or light or of temperature . Development of the flare may be 
longer than about 0 . 3 cm and shorter than about 0 . 5 cm . FIG . 45 tracked for example by reflectometry or thermometry . For 
11 illustrates a subject wearing a pump system an according example , the ratio of the reflected light of wavelengths 
to a specific example embodiment of the disclosure . A between about 600 and about 900 nm to that reflected 
needle may be narrow ( e . g . , between about 24 and about 33 between about 400 nm and about 900 nm may be monitored 
gauge and / or between about 26 gauge and about 30 gauge ) . to track the reddening . Alternatively , the decrease in the 
A needle may be connected directly to the drug reservoir or 50 reflected flux of white or yellow light may be monitored ; or 
it may be connected to the drug reservoir through tubing , for the temperature difference between the core of the flare and 
example plastic tubing . A pump may also be used to admin - a nearby skin site but off the flare may be monitored . 
ister one or more vaccines . A diagnostic system may have , other than the pump itself , 
Allergists now use skin tests to determine whether a two small compartments , of similar or different volumes . 
person has IgE antibodies in the skin that react to a specific 55 Each compartment may , independently , have a volume of , 
allergen . In these skin tests they inject subcutaneously , or for example , less than about 2 mL , less than about 1 mL , less 
apply to a scratch , series of about constant volumes of than about 0 . 5 mL , and / or less than about 0 . 2 mL . A system 
extracts of decreasingly diluted allergens , such as dust mites , may also comprise a hollow needle , which may be , for 
pollens , or molds found in the area in which the patient lives example , longer than about 2 mm and shorter than about 1 
or works . In a positive reaction , a small , raised , reddened 60 cm and / or longer than about 3 mm and shorter than about 6 
wheal , with a surrounding flare , appears at the test site . The mm . A needle may be narrow ( e . g . , between about 24 and 
inverse of the dilution of the injected allergen extract , its about 33 gauge and / or between about 26 gauge and about 30 
volume and size of the wheal allow the allergist to gauge the gauge ) . A needle may be connected , for example through 
relative sensitivity of a person to different allergens . plastic tubing , to an allergen suspension or solution contain 
According to some embodiments of the disclosure , the 65 ing reservoir . Tubing , part of which may be taped to the skin , 
tested allergen containing suspension or solution may be may be long enough to permit subcutaneous delivery of the 
subcutaneously administered by pumping , for example by a allergen suspension or solution at a site not covered by a 
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reservoir and pump comprising system . In some embodi needle may be inserted about vertically to the skin , for 
ments , tubing may be longer than about 1 cm , longer than example at an angle of at least about 60° versus the plane of 
about 3 cm , and / or longer than about 5 cm . A needle may be the skin , for example at least about 70° versus the plane of 
inserted below the skin at an off - vertical angle for shallow the skin , for example at least about 80° versus the plane of 
penetration and delivery of the allergen optionally in the 5 the skin . The solution or suspension of the allergen or 
outer part of the dermis that is proximal to the epidermis . For allergens may be administered for example until a sufficient 
example , a needle may be inserted at an angle ( versus but not excessive local inflammatory response is observed , 
vertical ) of at least about 50° , at least about 60° , at least exemplified by the appearance of a red , about circular , 
about 70° , and / or at least about 80° . region , of a diameter typically greater than about 2 mm and 
In some embodiments , a system may also comprise a 10 less than about 2 cm , typically greater than about 4 mm and 
factory or health care professional programmed electronic less than about 1 cm , or by local swelling , or by local 
system controlling the flow rate and monitoring the deliv - itching . Flow rate may be adjusted such that the inflamma 
ered dose of the allergen . This system may be optionally tory response may be projected to appear more than about 5 
incorporated , as shown for example in FIG . 6C , in the skin min after the start of the flow , for example more than about 
attached package . Unlike a drug reservoir , pumped aqueous 15 10 min , for example more than about 20 min , for example 
solution reservoir and / or an electro - osmotic pump of a more than about 30 min , for example more than about 1 
system , which may be discarded after use , an electronic hour , for example more than about 2 hours , for example 
control and display system may be separable , removable , more than about 3 hours , for example more than about 6 
and / or reusable . An electronic control and display system hours . When the inflammatory response is observed , the 
may be electrically connected to an electro - osmotic pump 20 delivery of the allergen comprising solution or suspension 
through contact pads , which both the re - used electronic may be discontinued and the system may be removed from 
control unit and the pump may have . Optionally , for safety , the skin . 
an electronic part of a system may provide a periodic alarm , A hollow needle 506 may be placed , as shown in FIG . 6C , 
alerting a patient or health care professional to check the below the skin attached system and covered by it . In some 
inflammatory response such as a wheal or flare . It may 25 embodiments , a hollow needle may be placed in a region 
discontinue flow of allergen solution or suspension unless a other than where the package is adhered to the skin , for 
patient or health care provider confirms that the inspection example , to allow visual inspection for the appearance of a 
did not show as yet sufficient inflammatory response . The flare or wheal or for visual confirmation that the needle is 
periods between the alerts may be fixed and / or user - select - properly implanted . A system may also comprise a hollow 
able . For example , the period between alerts may be less 30 needle , which may be , for example , longer than about 2 mm 
than about 20 min , less than about 10 min , less than about and shorter than about 1 cm and / or longer than about 3 mm 
5 min , and / or less than about 2 min . and shorter than about 5 mm . A needle may be narrow ( e . g . , 
Immunotherapy , typically involving weekly or twice between about 24 and about 33 gauge and / or between about 
weekly subcutaneous allergen injections for three years , 26 gauge and about 30 gauge ) . It may be connected to the 
provides relief after 1 year to 85 % of the patients . Inexpen - 35 allergen containing reservoir for example by a sufficiently 
sive drug pumps in general and particularly single - use long plastic tubing to allow easy observation of the evolu 
electro - osmotic pumps may be advantageously used in the tion of the inflammatory response at the delivery site . An 
immunotherapy of allergies . According to the present prac - immunotherapy system may have , other than the pump 
tice of immunotherapy , a series of increasingly concentrated itself , two compartments , of similar or different volumes . 
suspensions or solutions of the allergen or allergens to which 40 Each compartment may , independently , have a volume of , 
the patient is sensitive is subcutaneously injected . The for example , less than about 2 mL , less than about 1 mL , less 
solutions or suspensions are administered over an extended than about 0 . 5 mL , and / or less than about 0 . 2 mL . 
period of time , typically several years . The injections are system may also comprise a factory or health care 
believed to reduce the level of IgE antibodies in the blood professional programmed electronic system controlling the 
and to cause the body to make protective IgG antibodies . 45 flow rate and monitoring the delivered dose of the allergen . 
According to the present practice , the patient needs to visit This system may be optionally incorporated , as shown for 
the office of the allergist , wait to be injected by a nurse or example in FIG . 6C , in the skin attached package . Unlike the 
other health professional , and then wait at least about 20 min drug reservoir , pumped aqueous solution reservoir and elec 
to assure the absence of a severe allergic reaction to the tro - osmotic pump part of the system , which would be 
administered dose . The dosing is usually sub - optimal , 50 typically discarded after use , the electronic control and 
because the allergist wishes to be reasonably certain that display system would be removable and reusable . It may be 
there will not be a severe allergic reaction . Delivery of the connected to the pump through contact pads , which both the 
allergen suspension or solution over a period longer than re - used electronic control unit and the typically disposable 
about 5 min , for example longer than about 10 min , for solution and pump containing part would have . Optionally , 
example longer than about 30 min , for example longer than 55 for safety , the electronic part of the system may provide a 
about 1 hour , for example longer than about 3 hours , for periodic alarm , telling the patient or health care professional 
example longer than 6 hours would allow the patient to to inspect the extent of the wheal or flare . It may discontinue 
remove the skin - adhered system containing the electro - delivery of the allergen solution or suspension unless the 
osmotic or other drug pump when he or she observes patient or health care confirms the inspection . The periods 
excessive response , such as excessive reddening or swelling . 60 between the alarms may be typically of about less than 20 
An immunotherapy system of this disclosure is designed min , for example less than 10 min , for example less than 5 
to deliver an about optimal and always safe dose of the min , for example less than 2 min . 
allergen or allergens . Some , but not all components and As will be understood by those skilled in the art who have 
functions may be similar to those of the diagnostic system . the benefit of the instant disclosure , other equivalent or 
Because the delivery of the therapeutic doses may be 65 alternative compositions , devices , methods , and systems for 
generally in the dermis or in the tissue below the dermis , pumping a fluid ( e . g . , an active pharmaceutical ingredient , 
such as adipose tissue or connective tissue or muscle , the an allergen , a nutrient , a diagnostic agent ) can be envisioned 
39 
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without departing from the description contained herein . the reader . They include no admissions as to the scope and 
Accordingly , the manner of carrying out the disclosure as content of prior art and no limitations applicable to all 
shown and described is to be construed as illustrative only . disclosed embodiments . 
Persons skilled in the art may make various changes in the 
shape , size , number , and / or arrangement of parts without 5 EXAMPLES 
departing from the scope of the instant disclosure . For 
example , the position and number of a pump , cathode , anode Some specific example embodiments of the disclosure 
electrodes , tubing , PVC frames , PVC rings , reservoir , res may be illustrated by one or more of the examples provided 
ervoir chambers , hairpins , curvatures , controller , air gaps , herein . 
drug inlets , drug outlets , oil gaps , controller , processor , 
memory , power source , display , user interface , needle , adhe Example 1 : Pump Membrane 
sive , elastic band , and / or wires may be varied . In some An exemplary membrane was made by ( a ) adding 5 uL of embodiments , pump , cathode , anode electrodes , tubing , 
PVC frames , PVC rings , reservoir , reservoir chambers , 85 wt . % H3PO4 to 5 . 0 mL of a 10 wt % suspension of 1 um 15 diameter monodisperse silica microspheres ( Polysciences , hairpins , curvatures , controller , air gaps , drug inlets , drug Warrington , Pa . , Cat . # 24326 - 15 ) ; ( b ) evaporating the water outlets , oil gaps , controller , processor , memory , power at 65° C . ; ( c ) placing 65 mg of the resulting dried powder in source , display , user interface , needle , adhesive , elastic an 8 mm die and hand - pressing to form a pellet ; and ( d ) 
band , and / or wires may be interchangeable . In addition , the firing the pellet for 4 h at 700° C . The membrane was then 
size of a device and / or system may be scaled up ( e . g . , to be 20 washed with a sufficient volume of water to remove any 
used for adult subjects ) or down ( e . g . , to be used for juvenile unbound H3PO4 and dried . The 1 . 3 mm thick membrane 
subjects ) to suit the needs and / or desires of a practitioner . 
Each disclosed method and method step may be performed 
in association with any other disclosed method or method Example 2 : Electrodes Comprising Cerium Oxide 
step and in any order according to some embodiments . 25 
Where the verb “ may ” appears , it is intended to convey an Cerium oxide comprising electrodes of an electro - osmotic 
optional and / or permissive condition , but its use is not pump were prepared as follows : Carbon paper ( 3 . 6 cmx1 . 8 
intended to suggest any lack of operability unless otherwise cm ( 6 . 5 cm ) sheet of 130 um thick , 78 % porosity carbon 
indicated . paper ( from Toray ) ) was used as the base material and the 
Also , where ranges have been provided , the disclosed 30 carbon paper was plasma - treated , with a low pressure ( about 
endpoints may be treated as exact and / or approximations as 20 Torr or less ) air plasma for about 45 min . Timcal Super C45 carbon ( from Timcal USA , Westlake , Ohio ) , was made desired or demanded by the particular embodiment . Where hydrophilic by treating it with colloidal tin oxide . The tin the endpoints are approximate , the degree of flexibility may oxide treatment consisted of ( a ) mixing 100 mL distilled vary in proportion to the order of magnitude of the range . 28 35 water , 1 mL 15 weight % colloidal tin oxide ( SN 15 , Nyacol For example , on one hand , a range endpoint of about 50 in Technologies Inc . ) and 100 mg of Triton X - 100 ( Sigma 
the context of a range of about 5 to about 50 may include Aldrich ) , then adding to the stirred mixture 2 g of the Timcal 50 . 5 , but not 52 . 5 or 55 and , on the other hand , a range Super C45 carbon and continuing the stirring was for 1 hour . 
endpoint of about 30 in the context of a range of about 0 . 5 The solid was collected by filtration : the collected cake was 
to about 50 may include 55 , but not 60 or 75 . In addition , it 40 dried at 70° C . for 6 hours , transferred to a silica crucible , 
may be desirable , in some embodiments , to mix and match heated , with the temperature increased at a rate of about 10° 
range endpoints . Also , in some embodiments , each FIGURE C . / min to 320° C . , then firing at 320° C . for 10 min , cooling , 
disclosed ( e . g . , in one or more of the examples , tables , washing with distilled water and drying at 70° C . for 6 hours . 
and / or drawings ) may form the basis of a range ( e . g . , An about homogeneous cerium oxide - comprising paste 
depicted value + / - about 10 % , depicted value + / - about 50 % , 45 was prepared by mixing of 2 mL 5 % NAFION solution 
depicted value + / - about 100 % ) and / or a range endpoint . ( Sigma - Aldrich ) , 8 mL isopropanol ( Sigma - Aldrich ) , 500 
With respect to the former , a value of 50 depicted in an uL colloidal ceria sol ( CEO2 ( AC ) or CEO2 ( NO3 ) Nyacol 
example , table , and / or drawing may form the basis of a Technologies Inc . , Ashland , Mass . ] and 100 mg carbon 
range of , for example , about 45 to about 55 , about 25 to ( Timcal Super - C45 ) . Prior to its mixing with carbon , the 
about 100 , and / or about 0 to about 100 . Persons skilled in the 50 colloidal ceria sol was oxygenated for by passing through it 
art may make various changes in methods of preparing and gaseous O , for 10 min . The cerium oxide containing paste 
using a composition , device , and / or system of the disclosure . was applied to a 3 . 6 cmx1 . 8 cm ( 6 . 5 cm² ) sheet of 130 um 
For example , a composition , device , and / or system may be thick , 78 % porosity carbon paper ( Toray Carbon ) by dipping 
prepared and or used as appropriate for animal and / or human the carbon paper in the paste , removing it from the paste and 
use ( e . g . , with regard to sanitary , infectivity , safety , toxicity , 55 drying it at about 70° C . After drying , the now coated carbon 
biometric , and other considerations ) . paper was cleansed by boiling water and cut to form 8 mm 
All or a portion of a device and / or system for electro - diameter circular electrodes . 
osmotic pumping may be configured and arranged to be 
disposable , serviceable , interchangeable , and / or replaceable . Example 3 : Electrodes without Metallic Conductive 
These equivalents and alternatives along with obvious 60 Material 
changes and modifications are intended to be included 
within the scope of the present disclosure . Accordingly , the Substantially metal - free electrodes of an electro - osmotic 
foregoing disclosure is intended to be illustrative , but not pump may be prepared as follows : Carbon paper ( from 
limiting , of the scope of the disclosure as illustrated by the Toray ) may be used as the base material and the carbon 
claims below . 65 paper may be plasma - treated , with a low pressure ( about 20 
The title , abstract , background , and headings are provided Torr or less ) oxygen plasma for about 45 min and cut to form 
in compliance with regulations and / or for the convenience of 8 mm diameter circular electrodes . Alternatively , a paste of 
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hydrophilic Timcal Super C45 carbon made hydrophilic by wherein at least a part of the first side of the membrane is 
plasma treatment may be applied to carbon paper as in physical contact with one of the electrodes , and at 
described in Example 2 except without the colloidal tin least a part of the second side of the membrane is in 
oxide treatment . Carbon paper with the applied paste then physical contact with the other electrode 
may be plasma treated and cut as desired to form metal - free 5 wherein both of the electrodes are substantially free of 
electrodes . silver , platinum , palladium , nickel , copper , tungsten , 
molybdenum , alloys thereof , and compounds thereof ; 
Example 4 : Pump Assembly and Pre - Conditioning and 
wherein at least one of the electrodes is substantially free 
Assembly and Pre - Conditioning of the Pump . 10 of metal . 
The anode and the cathode of the pump were similar . The 2 . A direct current electro - osmotic pump according to 
pump was assembled as described in Application WO2011 / claim 1 , wherein the membrane comprises a porous ceramic . 
112723 A2 by sandwiching between two 8 mm diameter 3 . A direct current electro - osmotic pump according to 
electrodes an 8 mm diameter ceramic membrane of about claim 2 , wherein the porous ceramic comprises silicon . 
0 . 1 cm² volume and about 2 mm thickness . The assembly 15 4 . A direct current electro - osmotic pump according to 
was housed between two PVC rings with lips , with thin gold claim 3 , wherein the silicon is vitreous silicon dioxide . 
foils inserted between each electrode and the PVC housing - 5 . A direct current electro - osmotic pump according to 
rings for electrical contact . The assembly was then encap - claim 1 , wherein the lanthanide oxide or the actinide oxide 
sulated in a slow curing ( 24 h ) two - component epoxy resin comprises an oxide of cerium , an oxide of praseodymium , 
20 an oxide of thorium or combinations thereof . Example 5 : Pump Operation 6 . A direct current electro - osmotic pump according to 
claim 1 , wherein at least one of the electrodes comprises an 
Currents , Voltages and Flow . oxide of cerium as the lanthanide oxide . 
The applied voltage dependence of the flow through the 7 . A direct current electro - osmotic pump according to 
pump with the 8 mm OD electrodes and membrane ; Because 25 claim 1 , wherein the membrane is a polymeric - organic 
1 mm wide lips of the PVC rings prevented contact with membrane comprising a cation exchanger . 
water at the rim , the effective diameter of the circular water 8 . A direct current electro - osmotic pump according to 
pumping area was 6 mm , i . e . the water - contacting - area claim 7 , wherein the cation exchanging polymer comprises 
electrodes was 0 . 28 cm² . As seen in FIG . 15 the flow was sulfur atoms . 
constant when a particular potential was applied . When 1 V 30 9 . A direct current electro - osmotic pump according to 
was applied , the flow was about 7 uL / min , or about 25 uL claim 7 , wherein the cation exchanging polymer comprises 
min - 1 cm - 2 ; when 2 V was applied , the flow was about 15 fluorine atoms . 
uL / min , or about 54 uL min - cm - ? ; when 3 V was applied , 10 . A direct current electro - osmotic pump according to 
the flow was about 24 uL / min , or about 86 uL min cm . claim 7 , wherein the cation exchanging polymer comprises 
The discontinuities represent 10 min interruptions in the 35 perfluorinated polysulfonic acid . 
application of voltage . After each interruption , i . e . when the 11 . A direct current electro - osmotic pump according to 
voltage was re - applied , the flow resumed its pre - interruption claim 1 further comprising a pump fluid . 
rate . The flow increased about linearly with the applied 12 . A direct current electro - osmotic pump according to 
voltage ( FIG . 16 ) . claim 11 , wherein the pump fluid comprises water . 
40 13 . A direct current electro - osmotic pump according to 
Example 6 : Effect of Boiling the Water claim 1 , wherein the non - metallic electrochemically reactive 
component comprises carbon . 
As seen in FIG . 17 , the current at a constant applied 14 . A direct current electro - osmotic pump according to 
voltage and flow were reduced when the water placed in the claim 1 , wherein the carbon comprises woven or non - woven 
pump was freshly boiled ; boiling transiently reduced the 45 carbon cloth or paper , or carbon foam . 
concentration of the dissolved gases , such as CO2 and / or 02 . 15 . A direct current electro - osmotic pump comprising : 
The discontinuities seen are brief interruptions , after 90 min , a porous cathode and a porous anode and 
in the application of potential . FIG . 17 also shows that a a porous ceramic membrane between the cathode and the 
steady current is reached after about 10 min in un - boiled and anode , 
therefore air - equilibrated water , but it takes about 100 min 50 wherein the porous cathode and the porous anode each 
in boiled water , i . e . in water of which boiling removed the comprise a non - metallic electrochemically reactive 
dissolved air and which has not yet fully air - equilibrated . component that can gain a proton , gain an electron , lose 
a proton , lose an electron , or a combination thereof , and 
What is claimed is : at least one electrode further comprises a lanthanide 
1 . A direct current electro - osmotic pump comprising : 55 oxide , an actinide oxide , or both ; 
a pair of porous electrodes positioned at a distance from wherein at least a part of the surface of the membrane is 
each other ; and in physical contact with the anode and at least a part of 
a porous membrane comprising a first side and a second the opposite side of the membrane is in physical contact 
side , with the cathode ; 
wherein each electrode comprises a non - metallic electro - 60 wherein the porous cathode and the porous anode are each 
chemically reactive component that can gain a proton , substantially metal free . 
gain an electron , lose a proton , lose an electron , or a 16 . A direct current electro - osmotic pump according to 
combination thereof , and at least one electrode further claim 15 , wherein one of the porous cathode and the porous 
comprises a lanthanide oxide , an actinide oxide , or anode comprises cerium oxide as the lanthanide oxide . 
both ; 65 17 . A direct current electro - osmotic pump according to 
wherein the membrane is positioned between the pair of claim 15 , wherein the non - metallic electrochemically reac 
electrodes ; tive component comprises carbon . 
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18 . A direct current electro - osmotic pump according to 
claim 15 , wherein the carbon comprises woven or non 
woven carbon cloth or paper , or carbon foam . 
19 . A direct current electro - osmotic pump according to 
claim 15 , wherein the membrane comprises a porous 5 
ceramic . 
20 . A direct current electro - osmotic pump according to 
claim 19 , wherein the porous ceramic comprises silicon . 
21 . A direct current electro - osmotic pump according to 
claim 20 , wherein the silicon is vitreous silicon dioxide . 10 
22 . A direct current electro - osmotic pump according to 
claim 15 , wherein the lanthanide oxide or the actinide oxide 
comprises an oxide of cerium , an oxide of praseodymium , 
an oxide of thorium or combinations thereof . 
23 . A direct current electro - osmotic pump according to 15 
claim 15 , wherein the membrane is a polymeric - organic 
membrane comprising a cation exchanger . 
24 . A direct current electro - osmotic pump according to 
claim 23 , wherein the cation exchanging polymer comprises 
sulfur atoms . 
25 . A direct current electro - osmotic pump according to 
claim 23 , wherein the cation exchanging polymer comprises 
fluorine atoms . 
26 . A direct current electro - osmotic pump according to 
claim 23 , wherein the cation exchanging polymer comprises 25 
perfluorinated polysulfonic acid . 
27 . A direct current electro - osmotic pump according to 
claim 15 further comprising a pump fluid . 
28 . A direct current electro - osmotic pump according to 
claim 27 , wherein the pump fluid comprises water . 
* * * * * 
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